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ABSTRACT 
 
Jason Christopher Dyke: Designing Biomimetically Inspired Materials for Potential Orthopedic Tissue 
Engineering Applications 
(Under the direction of Wei You) 
 
Described herein is the progress made towards modifying and improving established 
Hydroxyapatite-Gelatin (HAp-Gel) bioceramics. Initial attempts to improve this composite were aimed at 
incorporating a biomimetic polymer into the HAp-Gel matrix in order to improve long-range interactions 
in the system. This was done in order to address shortcomings of HAp-Gelatin composites (e.g. low 
toughness) without sacrificing its favorable properties. Novel degradable copolymers were used, inspired 
by lactide and trimethylene carbonate monomers. These copolymers demonstrated tunable properties (e.g. 
molecular weight, glass transition temperature) and were shown to improve fiber bridging in a composite, 
without sacrificing biocompatibility. Unfortunately, these composites were plagued by poor interfacial 
adhesion.  
To address this, a catecholamine based polymer, polydopamine (PD), was incorporated into this 
HAp-Gel ceramic matrix. This macromolecule has demonstrated excellent adhesion to numerous 
substrates. This PD containing composite was shown to have a strong dependence of mechanical 
properties on processing temperature. Specifically, it was shown that at low temperatures, PD is able to 
polymerize unimpeded, while the sol-gel component is hindered. The sequential PD/sol-gel 
polymerizations leads to a unique interpenetrated polymer network with excellent mechanical properties 
and good biocompatibility.  
Finally, studies about catecholamine adhesives were expanded in order to study the structure-property 
relationship which leads to their remarkable polymerizations and adhesive properties. It was found that 
 iv
unbound catecholamines (e.g. catechol with propylamine) behave similarly to bound catecholamines such 
as dopamine. This result has profound implications on the design and implementation of catecholamine 
based adhesives, and further tests are underway to determine their ability to replace dopamine in 
bioceramic composites. 
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CHAPTER 1: INTRODUCTION TO CURRENT BONE-REPAIR MATERIALS AND 
DESIGN STRATEGIES 
 
 Bone injuries are caused by numerous factors such as disease, aging, or trauma. When 
left untreated, this damage can lead to chronic pain and loss of function, both of which will 
greatly lower a person’s quality of life and even expedite death It has been reported that every 
year, over 1.5 million American’s suffer a fracture caused by bone disease, and in 1995 the total 
expenditure for osteoporosis related treatments exceeded $13 billion in the United States.1 
Despite the prevalence of these injuries and the need to adequately replace the function of this 
damaged tissue, current treatment options remain limited due to the complexity of natural 
osseous tissue.  
Human bone is comprised of several different tissues, and in general, they share two 
common features. First, these tissues contain an inorganic component composed primarily of 
Ca10(PO4)6(OH)2, commonly referred to as hydroxyapatite (HAp). Second, they contain an 
organic component, composed predominately of the protein collagen. This structural protein is 
present in various connective tissues found in mammals, and indeed makes up a substantial 
portion of proteins found in mammalian extracellular matrix (ECM).2 In bone, the HAp mineral 
phase is embedded within a dense collagen organic phase, and these collagen macromolecules 
make the normally brittle inorganic apatites more flexible. This embedded structure helps to 
improve elasticity and toughness in natural bone. The toughening of bone is accomplished by 
more than simply adding collagen to mix though; in fact the HAp phase nucleates directly from, 
and ultimately encapsulates these collagen fibers. Following this encapsulation, the inorganic 
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and organic components are highly organized on several levels to form a complex hierarchical 
structure, illustrated in Figure 1.1.3  These HAp-coated collagen fibers are wound together to 
create larger mineralized collagen fibrils, which can be formed into lamellar sheets, which 
ultimately wrap together to form the final bone tissue. The intricate, highly organized structuring 
of human bone helps it to achieve the remarkable mechanical properties (i.e. low weight with 
high compressive strength) that are crucial for skeletal function. 
 
Figure 1.1 Hierarchical structure of bone, starting with collagen nucleating HAp, and being formed into 
several layers to maximize mechanical strength while minimizing weight.   
 
Besides this hierarchical structure, the complexity of human bone also stems from the 
intricate mechanical and chemical bonding between HAp and collagen. Because of the complex 
bonding and organization observed in natural osseous tissue, damage is difficult to satisfactorily 
repair. As such, the prevalence of bone injuries has forced significant research to be focused on 
developing materials suitable for potential therapeutic orthopedic applications. Despite the 
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considerable advances which have been made to address these concerns, all current treatment 
strategies and materials have significant drawbacks. For this reason, replicating the properties of 
bone with natural or synthetic biomaterials remains an elusive goal.  
1.1 Limitations of Natural Bone Treatment Options 
Because of its unique structural organization and properties, natural bone presents the 
best match for replacing lost or damaged tissue. Although using bone is the ideal replacement, 
current methods utilizing natural tissue can have serious drawbacks. 
Replacing bone from natural sources,, called grafting, involves taking healthy tissue from 
a donor for implantation into the afflicted individual. Currently, several methods of graft 
treatments are available; allografting involves harvesting tissue from a genetically different 
donor of the same species, while xenografts involve taking donor tissue from animal sources. 
Both of these methods present unique challenges. For example, these foreign tissue grafts can be 
rejected at the implant site, due to the same immunologic factors observed with other transplants. 
This rejection by the host’s immune system can cause additional damage at the implant site.4 
Furthermore, these grafts  present a greater risk for infection than other replacement strategies, 
further complicating the potential therapeutic benefit.5 For these reasons, it is generally believed 
that autografts are a superior source of natural bone tissue. 
Autografts present an alternative to the foreign grafts mentioned above. This process 
involves harvesting bone tissue elsewhere on the patient’s body and transplanting it to the defect 
site. The source of this graft bone is usually the patient’s hip, specifically the iliac crest, or the 
rib cage. Autografting is favored as it removes the possibility for host rejection of the tissue and 
lowers the overall risk of infection.5 Autografts are not the panacea for bone repair, however, as 
this method also presents many potential drawbacks. An obvious concern with autografts is the 
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limited tissue supply, simply due to the lack of suitable donor sites on a patient. Autografts also 
present the risk of donor site morbidity, a complication which arises when tissue surrounding the 
newly excised begins to necrose, creating another bone injury while attempting to treat the first.6 
Though complications are not incredibly common using autografts, patients who require a 
substantial amount of tissue to be excised, or patients who are already immunocompromised 
experience greater risks of complications.7 In addition to this, many patients report chronic pain 
from the implant site, lowering the thereapeutic value of this approach.8 These possible 
complications ultimately make the autograft option impossible for some patients, and sub-
optimal for many more. The potential limitations and negative consequences grafting treatment 
options highlight the need for improvements through alternative synthetic treatments. 
1.2 Permanent Synthetic Bone Replacement Materials 
Although finding synthetic biomaterials to replace natural bone is an ideal solution to 
address the problems associated with tissue grafts, the complexity of natural bone makes 
replicating its properties with synthetic materials incredibly difficult. Despite this, three main 
types of synthetic materials have been established for use as therapeutic orthopedic materials; 
ceramics, metals, and plastics.9 Of these, the most successful materials for bone replacements 
have been ceramics and metals due to their high mechanical strength and resistance to corrosion. 
Plastics are less ideal to function as load bearing bone replacement materials because, in general, 
their mechanical properties are not sufficient for this purpose. Furthermore, they show low 
resistance to bulk erosion resistance,10 making them even less suitable for the mechanical 
stresses associated with normal skeletal function. However, the freedom of design and tunable 
properties associated with plastics have allowed for numerous uses in other, non-loadbearing 
functions in orthopedic applications, such as sutures, bone screws, tacks, and plates,11,12 as well 
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as in blends with other, stronger materials. 13-15 
 Most early attempts in designing bone replacement alternatives were focused around 
finding materials which would permanently assume the function of the injured tissue.16 The 
majority of these early implants were designed to be nonporous and inert. Through this strategy, 
it was hoped that the implanted material would not negatively interfere with the function of the 
body, nor would they be altered by implantation. By using inert materials, it was also believed 
that these materials would resist degradation through wear and corrosion, helping extend the 
lifetime of these materials to make permanent implantations feasible. Nonporous materials also 
seemed favorable  as they provided a complete barrier at the interface of the implant and the hard 
tissue, minimizing potential adverse interaction with the surrounding tissue. Several types of 
permanent, bioinert material implants were attempted, including silica and aluminum-oxide 
ceramics, as well as metals such as steel and titanium alloys. After implantation, these implants 
were usually observed to be sequestered by a fibrous tissue of variable thickness, allowing them 
to serve their purpose while not interfering with the body. 17 
In practice, these permanent implants have their own problems. For example, modulus 
mismatch between very hard metal or ceramic implants and the somewhat softer bone can lead to 
microdamage near the implant-bone interface.18 This damage can manifest itself in numerous 
ways. One concern is that friction at the interface can eventually lead to erosion of the implant. 
Even if the implant is completely inert, friction can cause the implant to release wear-particles 
through repeated mechanical loading associated with normal use. These wear particles can cause 
numerous adverse conditions, such as inflammation around the implant,19 or even toxic injury to 
the patient.20 Furthermore, damage near the implant can result in loosening of the implant 
itself.21,22 This loosening could eventually lead to mechanical failure of the implant,23 causing 
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additional injury and necessitating further surgery in order to repair the damage caused by the 
implant. Since these materials are designed to be permanent implants, it is often difficult to 
repair or replace them, leading to further complications and hindering the therapeutic value of 
this approach.  
Modulus mismatch between implant and bone can lead to other undesired effects on the 
function of the implant through a process known as stress shielding.  This occurs when a high 
modulus implant shields the surrounding bones from feeling mechanical loading associated with 
normal skeletal function.24 The lack of mechanical load reaching the surrounding tissue causes 
the native tissue to lose strength, as the body deems it a waste of resources to continue to 
maintain the osseus tissue surrounding the implant. This process leads to drastically weakened 
tissue, which is then more susceptible to future injury. Therefore, when stress on a tissue is being 
shielded by an implant, the risk of the surrounding tissue failing is just as important as the risk of 
the implant itself failing. 
Complications associated with stress shielding arise due to the way bone is maintained in 
the body. Through a process known as bone remodeling, osteoclast cells are constantly removing 
mature bone tissue through a process known as bone resorption. This tissue is replaced by other 
cells known as osteoblasts, which lay down new cellular matrix and are eventually mineralized 
within this matrix through a process known as ossification. This remodeling behavior, illustrated 
in Figure 1.2, has been shown to follow a process called Wolff’s law, which states that a healthy 
individual’s body will continuously remodel its own osseus tissue in response to changes in 
mechanical loading. This means that the bone of a healthy individual will become stronger in 
response to increased load on that particular bone. In this instance, remodeling occurs primarily 
to fix microdamage and fractures present through repeated, heavy mechanical loading.25   
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Figure 1.2 Resorption of osseous tissue by osteoblasts and macrophages, and the subsequent deposition 
of new tissue by ossification through osteoblast activity. 
 
Reinforcing these bones lowers the risk of future injury associated with heavy use, and this repair 
strategy allows the body to focus on the bones most affected (i.e. the most damaged) and 
reinforce them accordingly. Conversely, if the tissue stops feeling the effect of skeletal loading 
(i.e. it is being stress shielded) the remodeling behavior will result in the body resorbing the 
tissue.26 This happens because it is metabolically costly to maintain bone, and if the body 
recognizes there is no need to reinforce and maintain a portion of osseous tissue, it will degrade 
this tissue in order utilize the nutrients in a more useful way elsewhere.  
As there were many drawbacks to using totally inert, nonporous implants, alternative 
treatment strategies and materials were also investigated. It was found that porous inert 
bioceramics such as pure hydroxyapatite, and ceramic-coated metals (e.g. HAp-coated titanium) 
can allow for a small amount of osseous tissue ingrowth.27 This infiltration is called “biological 
fixation” as this ingrowth mechanically attaches the implant to natural bone. This ingrowth is 
accomplished via migration of cells into the pores of the implanted material allowing the cells to 
begin filling in these pores with newly synthesized proteins commonly found in the extracellular 
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matrix (ECM.)28 This newly laid ECM effectively attaches the new osseous tissue to the 
permanent implant, creating a strong mechanical bond between the two. At the same time, 
provided the pores are suitably designed, a channel is created between the newly formed ECM 
and the surrounding healthy tissue. This allows for nutrients to move into the new cells, and 
waste to be removed, effectively expanding healthy tissue into, and around, the permanent 
implant. This approach was observed to eliminate many negative consequences of other 
nonporous permanent implants, such as implant loosening and encapsulation.29 Despite the 
improvements these biologically fixed implants demonstrated over nonporous implants, major 
concerns such as modulus mismatch, and longevity remained important concerns, necessitating 
investigation of better materials. 
1.3 Temporary Bone Replacement Options and Scaffolds 
 There are other classes of ceramics, however, which are considered bioactive, allowing 
favorable interactions with biological tissue to take place at the implant surface. These materials 
are capable of achieving “bioactive fixation” whereby a material such as a bioglass can form a 
favorable interface with the tissue surrounding the implant.30 Bioactive fixation involves creating 
mechanical bonds like those seen with biological fixation, but in addition, strong chemical 
bonding is achieved through the implant material’s inherent ability to react with the body. Since 
these materials are somewhat similar to bone, and not inert towards the body, the newly forming 
ECM can effectively incorporate a small amount of these ceramic materials directly into itself.31 
This gives better adhesion than the biologically “fixed” implants mentioned above, simply by 
virtue of chemically bonding the implant material, to a limited degree, into the ECM of the cells 
which interpenetrate the scaffold after material implantation.  
  Advances in biomaterials science have identified another class of ceramic materials with 
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excellent potential for therapeutic applications: resorbable bioceramics.31,32 These materials are 
similar to the bioactive ceramics mentioned above, but they differ in several important ways. 
Primarily, these materials are not permanent, and are capable of degrading over a specified 
period of time. This allows the slow interpenetration of osseous tissue, which leads the 
“bioactive fixation” to happen continuously at the materials surface. Small portions of the 
material are incorporated into the newly forming ECM before degrading away, and as the 
material degrades it is slowly replaced by natural tissue. Table 1.1 gives examples of each of the 
classes of biomaterials discussed above, and gives a summary of their interactions with the body. 
Figure 1.3 summarizes different classes of biomaterials, and gives examples of each 
type, also briefly discussing how the body interacts with each of these different classes. As can 
be seen in Figure 1.3, implants with low relative bioactivity (e.g. Al2O3 or Si3N4) exhibit 
effectively no interfacial bone after long implantation times, indicating they are largely  
 
 
Table 1.1: Classes of Biomaterials and General Properties 
Material Type Examples Advantages Disadvantages 
Dense, nonporous, 
nearly inert ceramics 
and/or metal alloys. 
Al2O3,  Titanium or Steel 
alloys 
Si3N4 
Strong mechanical 
properties, relative ease 
of manufacture 
Stress shielding, fibrous 
encapsulation, possible 
release of wear-particles 
Porous, inert implants, 
allowing ingrowth of 
small amount of 
natural tissue 
Hydroxyapatite and 
HAp-coated metals 
 
“Biological Fixation” 
mechanical bonding, 
strong mechanical 
properties 
Longevity of implants, 
corrosion of material at 
interface, stress 
shielding 
Dense, nonporous, 
surface reactive 
materials allowing 
chemical bonding with 
natural bone 
45S5 Bioglass 
KGS Cervital 
55S4 Bioglass 
Bioactive fixation, good 
mechanical properties, 
excellent bone-implant 
interface, mechanical 
and chemical bonding 
Longevity of implant 
and often difficult 
fabrication 
Nonporous or porous, 
resorbable ceramics 
designed to be 
remodeled naturally 
Tricalcium phosphate, 
HAp-Gelatin, 
Plaster of Paris 
Utilizes natural healing 
pathways to remove 
implant and replace 
with healthy tissue 
Coordinating 
degradation and healing 
times, complex 
fabrication 
    
 
10 
partitioned from the rest of the body.  Implants that are largely inert but porous (e.g. pure HAp) 
show increasing percentages of interfacial bone, though the inert nature of these materials require 
long periods of time for substantial in-growth to be observed. Materials considered bioactive 
(e.g. various bioglasses) show very rapid increases in the interfacial bone content, demonstrating 
their ability to react favorably with newly forming surrounding osseous tissue. The materials 
which are considered to be resorbable have the highest relative reactivity, and present the 
opportunity for allowing constantly expanding interfacial bone as their interface is continuously 
degrading to be replaced by natural tissue.  
In recent years, these resorbable, bioactive materials have become fundamental in 
medical use for their ability to replace various types of natural tissue. Their unique properties 
allow them to be used to create a degradable, functional substitute for human tissues.  This is 
accomplished by processing these materials into scaffolds, which are designed to function as a 3-
D template which acts as a blueprint to direct different types of cells into the implant.32  For 
these applications, it is vital to ensure that the scaffold will be strong enough to withstand forces 
generated through skeletal function. This strength must be sufficiently high to allow for highly 
porous materials to be used, allowing the 
ingrowth of native cells.33  
 
Figure 1.3 Interfacial bone content and 
relative reactivity of several established 
commercial biomaterials.  Bioactive materials 
(A-D) show the largest ingrowth of bone 
(excluding resorbable materials.) Porous 
materials show good interfacial bone content 
after sufficiently long implantation time (E-F) 
Inert materials (G) show minimal interaction      
with surrounding tissue 
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Different materials are used for their mechanical and biochemical properties to replace 
various tissues.12 Many polymers are capable of functioning for soft tissue repairs, while various 
bioceramics have shown promise in replacing bone. Materials suitable for scaffolding bone are 
called osteoconductive, for their ability to promote the growth of healthy osseous tissue. Since 
these scaffolds are designed to degrade over time, they allow the cells to continuously create 
healthy tissue at the implant tissue interface. As the scaffold degrades, either enzymatically or 
hydrolytically, the interface continuously expands as well. This ensures that new, healthy ECM 
is constantly being laid by ingrown cells as the material degrades. To expedite this healing 
process, these scaffolds can also be doped with a combination of stem cells, or partially 
differentiated cells and growth factors to help facilitate more efficient healing.34 This approach 
allows for the body to heal itself more gradually, while the scaffold serves as a temporary matrix 
providing structural support and protection for the wound site along with cells vital to the healing 
process.  
An important consideration for designing scaffolds is the coordinating the implant’s 
degradation time with the rate of healing, ensuring a gradual transfer of physiological load from 
the scaffold to new tissues. Degradation time can be influenced by a number of factors, such as 
material composition, processing method, and pore size.35 As the scaffold degrades, the 
interpenetrated cells continue to remodel the matrix. This remodeling will begin to slowly 
transfer load-bearing function away from the scaffold and onto the newly laid ECM.. This allows 
in-grown cells to gradually feel forces associated with their normal function. As mentioned 
before, the body will continuously reinforce bone matrix according to Wolff’s law ,36 so as these 
cells gradually feel increased mechanical loading, they will respond in kind by constantly 
reinforcing their own matrix to accommodate this increased load.  As the scaffold slowly 
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degrades, it allows the ECM to gradually experience greater mechanical loading. The progressive 
loading from the implant to healing tissues causes many cycles of this remodeling to occur 
slowly as the scaffold degrades.37,38 This loss of mechanical strength and subsequent transfer of 
load to the newly formed, natural tissue in an idealized scaffold is illustrated in Figure 1.4.35  
This ensures the delicate new tissue is not required to support full physiological load until it has 
become sufficiently strong, preventing further injury from occurring while the body is still 
healing.38 This behavior creates a completely natural tissue to replace a damaged one, effectively 
avoiding many of the negative aspects of allografts and permanent implants. 
 
 
Figure 1.4 shows an idealized representation of 
the loss of mechanical strength of implanted 
materials associated with the degradation of 
that material in vivo. The loss of strength is 
compensated by the remodeling of this material 
into natural osseous tissue, allowing a gradual 
transfer of load onto new tissue, and ensuring a 
sufficient strength to be maintained through the 
combined load bearing ability of both the 
implant and natural tissue. 
 
 
In light of required robust physical properties, and specific surface chemistries necessary 
for successful orthopedic scaffolds, several materials have been identified to possess qualities 
that show great potential. Materials such as hydroxyapatite,39,40 tricalcium phosphate 
(TCP),13,39and Calcium Phosphate Cement (CPC)41  have received significant attention for use in 
orthopedic applications due to their superb biocompatibility, high strength, and good 
osteoconductivity.42 However, despite these favorable properties, these materials are not ideal for 
all bone scaffolding applications. Indeed, the high strength of these materials is hindered by their 
brittle nature and slow degradation time, necessitating research into new biomaterials. 29,39 
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1.4 Hydroxyapatite-Gelatin Composite Materials 
In response to the need for new bone replacement materials, Ko et al. created a novel 
bioceramic by blending hydroxyapatite with gelatin, forming a composite referred to as HAp-
Gel.43. Rather than utilizing collagen (specifically type-1 collagen) as the organic phase of this 
composite, as is seen in bone, HAp-Gel uses the hydrolyzed form of collagen known as gelatin. 
This replacement had profound implications on the composite. On one hand, gelatin is a cheaper 
alternative than collagen, making this an attractive material to study in terms of making 
biomaterials accessible to a wider range of patients. Additionally its properties show lower batch 
to batch variation than collagen. Because of the hydrolysis of collagen to gelatin, purification and 
processing have less impact on the final structure. Alternatively, this material loses much of 
toughening associated with collagen, as the hierarchical structure of bone is not maintained 
during HAp-Gel processing. However, a substantial mechanical binding is present. It was 
observed that as the carboxylate groups of gelatin are responsible for HAp nucleation and 
growth, maintaining some degree of robust mechanical properties required for these implants.43 
In principle, HAp-Gel did successfully mimic the composition of natural bone, and was 
also able to demonstrate promise for in vivo and in vitro resorption. This material demonstrated 
shorter degradation times than pure HAp materials, making it more useful as a potential 
temporary scaffold material.43 However, challenges remain in developing useful scaffolds from 
these composites as they demonstrate poor processability when wet, and insufficient toughness 
when porous. Initial attempts to increase toughness were made by adding a cross-linker, 
glutaraldehyde (GA), and this route ultimately did yield to materials with better mechanical 
properties. HAp-Gel/GA materials were not suitable for scaffolding materials, however, as 
negative consequences were observed from unreacted GA, as well as the inability to form 
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sufficiently strong materials when porous.44,45 Unfortunately, greater strength in these 
composites was shown to be related to increasing GA content, however, increasing GA content 
was also shown to decrease cell viability.  The need for these materials to maintain sufficient 
mechanical properties when porous is an important consideration for potential scaffolding 
materials. Without this porous architecture, cells are unable to interpenetrate and ultimately 
remodel the scaffold, making these materials useless for tissue engineering applications. Though 
good initial results were obtained, demonstrating the promise of HAp-Gel based materials, the 
negative results also highlighted the need to investigate new cross-linking chemistries.  
Problems with HAp-Gel/GA samples were ultimately improved by incorporation of a 
different cross-linking agent (N, N’-bis [(3-trimethoxysilyl)propyl]ethylene diamine, commonly 
referred to as (enTMOS).46 This cross-linker utilizes a common sol-gel process, the condensation 
polymerization of trialkoxysilanes, which yields a bioactive glass, which is demonstrated in 
Figure 1.5. 
 
 
 
 
 
 
Figure 1.5 Hydrolysis condensation reaction leading to cross-linked sol-gel materials.  
 
This sol-gel approach to cross-linking HAp-Gel yields a material referred to as 
hydroxyapatite-gelatin modified silane (HAp-Gemosil). It was shown that enTMOS was able to 
strongly bind HAp-Gel further helping to strengthen this composite. This binding came from the 
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ability of enTMOS Si-O bonds to interact with PO4
3- present in HAp-Gel. Furthermore, the 
amines on enTMOS were observed to hydrogen bond with carboxylate groups on gelatin, further 
strengthening this interaction.  HAp-Gemosil also had numerous other advantages over previous 
HAp-Gel based materials, including faster setting time, better processability when wet, better 
stability after setting, and the ability to fill arbitrary shapes. This last property is especially 
important when trying to reconstruct bony defects, such as those caused by cancer or other non-
traumatic bone injuries. Furthermore, it demonstrated excellent compressive strength, and also 
the ability to form a porous material through the use of salt-leaching techniques. Salt-leaching 
was shown to effectively yield HAp-Gemosil materials with tunable pore size, though pore size 
was shown to be inversely proportional to mechanical strength. This material proved to be an 
excellent substrate for the spreading and proliferation of MC3T3-E1 preosteoblasts. These cells 
were shown to migrate into and spread out over the material, suggesting a favorable substrate for 
cellular interaction. Furthermore,  alkaline phosphatase activity assays also showed that these 
materials also did not hinder metabolic activity or differentiation of plated preosteoblasts.45,46 
These results are shown in Figure 1.6.  
 
 
 
Figure 1.6 (Left) SEM 
image of porous HAp-
Gemosil Material, 
(Upper right) Strength 
related to pore size and 
(Lower right) ALP 
activity on porous HA-
Gemosil 
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This material also demonstrated signs of osteoconductivity. Alizarin red stains were used 
to demonstrate mineralization patterns in vitro, as shown in Figure 1.7. In these studies, it can 
clearly be seen that cells plated on HAp-Gemosil samples were observed to create mineralization 
patterns that are similar to those observed in trabecular bone. The pattern observed for the 
control sample saw a relatively homogeneous dispersion of spots with no clear connectivity 
between the spots. The patterned formation on the Gemosil plates is reminiscent of a 2-D 
construct of osseous tissue, and it was observed that osteoblasts were found to spread over the 
interconnected mineralized pattern, with no cells observed between the network. This is in 
contrast to the control group which showed cells covering over the entire surface. This implies as 
the HAp-Gemosil component degrades, it could be remodeled by osteoblasts into an 
interconnected network similar to natural bone. The combination of these properties, plus the 
relative ease of processing and low cost of HAp-Gemosil materials made this an excellent 
potential scaffold material for further studies.  
Though HAp-Gemosil materials demonstrated significant potential as scaffold materials, 
they weren’t without flaws. While this material had excellent compressive strength, the flexural 
strength was too low for consideration in clinical applications.45,46 The high strength but low 
toughness of this material was not well suited for in vivo applications due to concerns  about the 
possibility of brittle implant failure, and modulus mismatch. The problems of low toughness 
were also exacerbated when these composites were porous, making this material unlikely to be 
useful for current clinical applications. Furthermore, though the siloxane matrix is bioactive and 
allows the ingrowth of new bone tissue, it is still a permanent component of this composite, 
leading to questions about its interaction in the body on a time scale relevant for permanent 
implants. Ideally, all components of this composite would be degradable, 
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Figure 1.7 Viability assays(a-b) and mineralization studies(c-d) of osteoblast plated on control and HAp-
Gemosil. Control samples showed good cell viability (a) but no clear remodeling behavior (c) contrasting 
with Gemosil showing similar viability (b) and also signs of preliminary remodelling (d) 
 
in this way; negative side effects of potentially toxic byproducts and long term stability of the 
implant are both avoided.  
Initial results with various HAp-Gel based systems have demonstrated that the 
hydroxyapatite-gelatin is an excellent starting point for designing and investigating orthopedic 
tissue scaffolds. Numerous considerations must be taken into account when planning for and 
designing new materials based on previous results in order to ensure that favorable properties are 
not diminished when addressing the shortcomings of previous materials. One way to do this is 
through biomimetic design, whereby examples in nature are used to guide the design of new 
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materials. Based on this rationale, it can be seen that the one thing all of these previous 
composites lacked was a suitable mimic for the collagen found in natural bone. This is an 
important component of the composite as a substantial amount of bone’s toughness comes from 
collagen being mineralized within the HAp matrix as it grows.3 So it naturally follows that it is 
possible to incorporate polymers into these HAp-Gel composites to mimic the role of collagen 
that is not preserved when gelatin is substituted for collagen. In the above examples, all of the 
cross-linkers (e.g. enTMOS, GA) used were utilized in order to maximize short range 
interactions in the composite, allowing for improved mechanical strength. By mimicking 
collagen with a synthetic polymer, these composites can benefit from additional long range 
interaction. This allows distant portions of the composite to connect physically and chemically, 
which is vital for improving flexural strength and toughening a composite by helping to 
delocalize stress throughout a larger area of the material and prevent damage.  
As mentioned previously, polymers on their own are not well suited for orthopedic 
scaffolding applications due to their low mechanical strength. However, extensive work has been 
done blending polymers with various inorganic materials,14,39 and this approach has been shown 
to improve the performance of these biocomposites by altering their degradation profiles and 
softening these high modulus materials.10,11 Synthetic polyesters such as poly(lactic acid) 
(PLLA),9,47,48 poly(glycolic acid) (PLGA)49, poly(ε-caprolactone) (PCL)13,40 and 
poly(trimethylene carbonate) (PTMC)50-53 have been investigated in blends for a variety of 
medical applications.  Each of these polymers has unique mechanical and degradative properties 
allowing them to be utilized in a wide range of biomaterials. Though homopolymers have good 
properties for in vivo applications, they are often limited by their diversity in function. The 
utilization of copolymers presents significant synthetic freedom in design,49 allowing properties 
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to be isolated and optimized in order to maximize toughness of a composite.49,51 This 
optimization can come from choice of monomers, type of architecture (i.e. diblock, triblock, 
random, alternating) molecular weight, and final material processing (e.g. braided fibers, sintered 
bulk material etc.) Therefore, copolymers present a useful way to tune the properties of 
biocomposites such as crystallinity, glass transition temperature (Tg), modulus, degradation 
behavior and mechanical strength, all of which can be specifically optimized for use in preparing 
scaffolds. 51,54 
In light of these design parameters and the success of previous HAp-Gemosil composites, 
it was decided to construct a degradable bioceramic/polymer composite. It was hypothesized that 
cross-linking a polymer inspired by enTMOS with the HAp-Gemosil composite would allow for 
better long-range order, leading to better load bearing and processability of the material when 
compared to non-polymeric enTMOS blended composites.  This biomimetic approach would 
allow for improved interfacial adhesion over other polymer blends based on physical cross-
linking only. Additionally better long-range order could be obtained when compared to 
composites that are only cross-linked by small molecules. Cross-linking a biocompatible 
polymer into hydroxyapatite-gelatin nanocomposites will better mimic the short and long range 
interactions seen in natural bone and optimize toughness while retaining bioactivity of the 
bioceramics.15  
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CHAPTER 2: PERFORMANCE OF BIOCERAMIC COMPOSITES CONTAINING 
POLY(L-LACTIDE-CO-PROPARGYL CARBONATE)-G-AZIDO SILANE 
 
2.1. Introduction to Polymer Bioceramic composites 
 Natural bone is a lightweight mineral composite consisting of inorganic apatite, mainly 
hydroxyapatite (HAp), within a dense matrix of organic collagens.  The long fibrous collagen 
makes the normally brittle HAp more resilient, helping to improve flexural strength in natural 
bone.1  The hierarchy HAp-collagen structure, however, cannot be reproduced easily using 
engineering principles.  Sequentially, autografts (tissues from the host) have become the gold 
standard for replacement of damaged tissues.  
Due to the drawbacks (e.g., donor site morbidity, shortage of resources) of autografts, the 
need for alternate alloplastic materials is clear.  Orthopedic biomaterials, in particular, have been 
heavily studied, and comprehensively reviewed by Puppi2 and Shoichet3 in greater detail.  In 
particular, significant progress has been achieved in engineering materials capable of degrading 
in vivo, either by hydrolytic or enzymatic activity to promote formation of natural osseous tissue, 
through growth of tissue into the composite material.4   
 This biodegradable approach allows for the body to heal itself more gradually, with the scaffold 
serving as a temporary matrix until sufficiently strong osseous tissue can assume a physiological 
load.5,6  
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In response to the needs, several classes of biocompatible and biodegradable polymers 
have been established for numerous medical applications.  Polyesters such as poly(lactic acid) 
(PLLA)7-9, poly(glycolic acid) (PLGA)10, poly(ε-caprolactone) (PCL)11,12 and poly(trimethylene 
carbonate) (PTMC)13-15 have been investigated as native or as in blends16,17 for a variety of 
medical applications. Each of these polymers has unique mechanical and degradative properties 
allowing them to be utilized in a wide range of biomaterials.2,3,18-21 Though homopolymers have 
good properties for in vivo applications, they are often limited by their diversity in function. 
Therefore, copolymers present a useful way to obtain tunable properties such as molecular 
weight, crystallinity, glass transition temperature (Tg), modulus, degradation behavior and tensile 
strength, all of which can be specifically optimized for use in preparing scaffolds.10,13 
Furthermore, the structure of many of these monomers can be synthetically altered to tailor their 
properties. These monomers can be combined in nearly endless ways to form functional 
materials with application specific properties. Because of this, it is important for synthetic 
chemists to formulate new monomers and design new monomers and polymers in an attempt to 
improve the utility of materials engineered for specific applications.   
Recently, Ko and co-workers created a composite of Hydroxyapatite-Gelatin (HAp-
Gel)22 that mimicked the natural composition and properties of bone23 and was able to 
demonstrate promise for in vivo and in vitro biocompatibility.24  However, challenges remained 
in developing useful grafts from these composites because they demonstrated poor processability 
and insufficient strength when porous.  These problems were ultimately improved by 
incorporation of an additional cross-linking agent, (N, N’-bis [(3-trimethoxysilyl)propyl]ethylene 
diamine (enTMOS).25  This small molecule is capable of undergoing hydrolysis-condensation of 
alkoxy-silanes to produce a silsesquioxane matrix within the hydroxyapatite-gelatin modified 
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siloxane (HAp-Gemosil) composite.  This helps give additional structural support to the 
composite and can help impart the network strength of the silane matrix into the composite, 
leading to enhanced mechanical properties and molding ability.  While this matrix did improve 
the compressive strength and processability of the composite, the short chain siloxane based 
matrix was brittle and still susceptible to tensile failure.  It was clear that a more robust 
composite was needed in order to further advance this system for potential scaffolding 
applications.  One possible solution is to design and incorporate a biocompatible and cross-
linkable polymer of sufficient chain length into the composite.  
First, we chose a copolymer of PLLA and PTMC to blend into Hap-Gemosil composites. 
PLLA has demonstrated previous success in use with hydroxyapatite ceramic composites,16,26,27 
and PLLA’s biocompatibility has long been established. However, at physiologic temperature, 
PLLA is brittle and can contribute to low composite strength.28 Therefore, an amorphous TMC 
derivative, Propargyl Carbonate (PC), was synthesized and utilized as the co-monomer. This 
monomer can act to soften PLLA and toughen brittle composites29, as demonstrated in previous 
studies where P(LLA-co-TMC) copolymers showed a decrease in Tg with increasing TMC 
incorporation.30-32 The combination of both properties from PLLA and PPC (a derivatized 
PTMC) polymer could help P(LLA-co-PC) copolymers to exhibit good flexural strength and 
elongation, ideal for creating a more robust ceramic composite. In addition, both PLLA and 
PTMC polymers have unique degradative properties, allowing the degradation behavior of future 
composites of this formulation to be controlled. Finally, from the synthetic perspective, both of 
these monomers are ideal candidates for ring-opening polymerizations (ROP), whereby 
byproducts are avoided and polymers of high MW can be readily obtained.31-33 Since both 
monomers share a common method of polymerization, copolymer composition is more easily 
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controlled. More importantly, cyclic carbonates can be easily derived34 and the modifications 
present on PC would allow the incorporation of a pendant silane graft monomers onto the 
polymer backbone (vide infra), while also imparting similar properties to PTMC.  
Second, we designed the chosen copolymer to cross-link within the HAp-Gemosil 
composite because this would lead to improved tensile strength via better long range interaction 
when compared with physically blending polymer into the composites. Specifically, this 
approach – designing polymers with cross-linkable grafts – would provide two advantages: (a) 
increase interfacial adhesion over polymer blends, and (b) enhance long range interactions when 
compared with composites that are only cross-linked by small molecules (e.g., enTMOS). 
Consequently, the composite would more effectively mimic the short and long range chemical 
interactions seen within bone, thereby improving tensile strength of the composite.35 This should 
in turn help to resist tensile loading by distributing forces more evenly through the composite, 
rather than at the point of application.36 Since HAp-Gemosil composites were originally cross-
linked using an amino-silane (enTMOS), it would be ideal to design the copolymer to bear a 
similar cross-linkable silane group.  
However, the sensitivity of the graft monomer’s silane groups precluded their direct 
incorporation prior to polymerization. Therefore, we employed the CuAAC Chemistry (‘Click” 
reactions) to impart the silane functionality to the polymer via post-polymerization 
functionalization by quantitatively coupling the graft monomer azide to the main chain alkyne of 
the polymer backbone.37,38 Thus the PC monomer was synthesized to bear a pendant acetylene 
group, while the azide functionality was linked with the silane (e.g., 5-azido-N-(3-
(trimethoxysilyl) propyl) pentanamide). After the copolymerization of LLA and PC, the terminal 
alkyne group of the copolymer would easily react with the azido-silane (AS) graft monomer via 
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CuAAC chemistry. This post-polymerization functionalization approach allows the grafting of 
the silane functionality to occur after polymerization, ensuring the fidelity of the silane groups is 
maintained. P(LLA-co-PC)(AS) can then be blended with HAp-Gel and cross-linked in the 
presence of enTMOS to produce a fully cross-linked composite through hydrolysis–condensation 
of trialkoxysilyl groups present on both the copolymer and enTMOS. Such programmed 
composite would improve adhesion through coordination of grafted amide and triazole groups to 
free carboxylate groups on gelatin and also through silane cross-linking to HAp. 
Based on this rationale, we have synthesized and characterized a series of P(LLA-co-PC) 
polymers via Ring-Opening Polymerization (ROP) and functionalized the polymers with pendant 
silanes. Composites formed by incorporating these polymers with HAp-Gemosil were easily 
molded and set quickly. To determine the impact of blending P(LLA-co-PC)(AS) with HAp-
Gemosil, transwell plates were filled with this new composite material and preosteoblasts 
MC3T3-E1 were cultured in the bottom of these plates for 21 days. It was observed that 
throughout this period, the growth curves of cells in the presence of either HAp-Gemosil or 
HAp-Gemosil/P(LLA-co-PC)(AS) composites were very similar, suggesting that the synthesized 
polymer can help improve mechanical properties without negatively impacting the 
biocompatibility. In addition, both materials showed similar cellular growth curves to those of 
the control samples, suggesting these materials provide a suitable substrate for cellular 
attachment and proliferation. Furthermore, biaxial bending tests were undertaken to determine 
the impact that incorporating P(LLA-co-PC)(AS) into a ceramic composite has on flexural 
strength. It was also observed that this polymer helped increase fiber bridging within the 
composite, leading to higher flexural strength than that of non-polymeric HAp-Gel composites. 
These results suggest that the design of this copolymer, and the use of graft monomers as cross-
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linking agents possess merit for future study in expanding their applications for bioceramic 
composites.  
2.2 Monomer and Cross-Linker Synthesis 
The hydrolysable cyclic TMC inspired carbonate monomer, propargyl carbonate (PC), 
was synthesized in good yield over  four steps from established methods39 as shown in Figure 
2.1.   
 
 
 
 
 
 
 
Figure 2.1 Synthesis of PC monomer from 1,1,1-Tris(hydroxyl methyl)ethane (THME) 
 
Due to the sensitive nature of both the azide and silane groups on the graft monomer 
molecule, azido-silane (AS), it is important to utilize a synthesis that would allow for highly pure 
products in nearly quantitative yields over all steps under mild conditions. The chosen route is 
highlighted in Figure 2.2.  To accomplish this, 5-Bromovaleryl chloride was first reacted with 3-
aminopropyl trimethoxy silane to yield 5-bromo-N-(3-(trimethoxysilyl)propyl)pentanamide (G1 
in Figure 2.2).  An SN2 reaction with sodium azide was then performed to yield 5-azido-N-(3-
(trimethoxysilyl)propyl)pentanamide (AS, G2 in Figure 2.2).  Both steps offered products in 
nearly quantitative yield with no need for purification as confirmed by NMR. 
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Figure 2.2 Synthesis of enTMOS inspired, azido-silane graft monomer (AS) 
 
2.3 Synthesis and Characterization of Copolymers from Sn(Oct)2 Catalyzed ROP 
TMC homopolymer and PLLA have different physical properties,18,19 therefore the 
percent incorporation of the PC unit (a TMC derivative) in the copolymer would impact 
important polymer properties such as molecular weight and Tg.
28,30-32,34  More importantly, these 
properties would determine whether or not the newly designed copolymers are suitable for 
specific applications.17  Therefore, understanding the polymerization behavior and related 
properties of the copolymers precedes the development of composites. To accomplish this, we 
systematically varied the mol% PC in the load (0 – 100%) to investigate its effect on the 
polymerization and properties of the copolymer. This information would assist in future 
composite planning by helping elucidate the underlying chemistry that dictates polymer 
properties, since these polymer properties will determine how polymers interact within a ceramic 
composite. The copolymerization was carried out at 120 ºC in toluene and for 20 hours using a 
Sn(Oct)2 catalyst and 4-tert-butylbenzyl alcohol as the initiator (Figure 2.3). Sn(Oct)2 was 
chosen because its versatility in ROP catalysis and ability to run at high temperature.  4-tert-
butylbenzyl alcohol initiator was employed since its steric bulk can help inhibit intramolecular 
chain trans-esterification during polymerization.   
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Figure 2.3 Ring-opening copolymerization of L-Lactide (LLA)  and the TMC derivative monomer, 
Propargyl Carbonate (PC) 
 
1H NMR was used to determine the ratio of incorporated carbonate to lactide in the polymer by 
comparing integrations of carbonate methyl (δ = 0.995 ppm) peaks and lactide methine (δ = 5.18 
ppm) peaks, while GPC traces were taken from a THF solution of polymer to determine the 
molecular weight.  The number averaged molecular weight (Mn) and %PC incorporation are 
plotted against the mol% PC loading in Figure 2.4A and 2.4B respectively.  The most notable 
feature from Figure 2.4A is that the Mn decreases with the increased loading of the PC 
monomer, similarly observed by Gu et al. in a recent study.31 Interestingly, the mol% 
incorporation of PC in the copolymer, shown in Figure 1B, is consistently lower than the mol% 
PC loading.  Both of these observations can be attributed to the faster rate of polymerization of 
LLA compared with that of PC as previously reported for similar TMC-LLA copolymers.30 
Previous reports of lactide-carbonate copolymerizations showed that reaction times of >48 hours 
are needed to obtain high molecular weight copolymers that incorporated a high molar fraction 
of carbonate monomers.31   
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Figure 2.4. Copolymerization behavior of LLA-PC Ring Opening Polymerizations  (A) Polymer 
molecular weight (Mn) as a function of increasing %PC load.  (B) %PC present in the polymer chain as a 
function of mol fraction loaded before polymerization. 
 
However, at these elevated temperatures and reaction times, PLLA segments could 
thermally degrade more readily than polycarbonate segments.30  In our cases, LLA is consumed 
faster than PC, resulting in a portion of PC monomers not being incorporated into the copolymer 
chain in the chosen reaction time (20 h).  Instead, these unconsumed PC monomers form low 
molecular weight (MW) chains (2 – 4 kDa) consisting primarily of poly-propargyl carbonate, or 
remain as unreacted PC monomer.  Due to the low MW and rubbery nature of PC, both remain 
soluble in methanol and are washed away during precipitation.  
Detailed NMR analyses of all polymers elucidate further structural information of these 
polymers and the random nature of the copolymerization.  To identify the chemical origin of 
each shift in the copolymers, a transition from PLLA homopolymer to PPC homopolymer with a 
P(LLA-co-PC)44.6% copolymer is shown in Figure 2.5A.  The most interesting and diagnostic 
feature comes from the lactide protons (Figure 2.5B).  In low mol %PC samples, a single peak is 
observed for the methine protons at δ = 5.18 ppm(proton a in Figure 2B).  As the mol %PC 
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increases, this methine signal begins to split, with a second peak appearing at δ = 5.02 ppm 
(proton b in Figure 2.5B).  This secondary methine peak arises as a result of inductive effects on 
those methine peaks that neighbor a carbonate unit.  These protons would feel a weaker de-
shielding effect due to the lower electron withdrawing nature of the carbonate when compared 
with the ester in LLA, and thus will be shifted slightly upfield.  This effect is observed only in 
LLA methine protons that are adjacent to a carbonate in the copolymer.  During the 
copolymerization, if a propagating polymer chain end belongs to a lactide monomer and this 
“lactide” chain end opens up another lactide monomer, then all methine peaks are equivalent and 
no alternate shift is observed.  When the propagating “lactide” chain end attacks a carbonate  
 
 
Figure 2.5(A) NMR spectra for PLLA and PPC homopolymers, as well as a 44.6% PC Containing 
P(LLA-co-PC) copolymer, illustrating the rise of a secondary methane peak, indicating a statistically 
random polymerization. 2.5(B) Shows this secondary methane peak growing as the %PC in the 
copolymer increase. 
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however, the additional oxygen on newly incorporated carbonate carbonyl helps slightly 
shield the α-methine proton that is next to the carbonate and leads to the appearance of a second 
peak upfield of the first (Figure 2A).  This splitting effect is highlighted in Figure 2B.  The 
relative ratio of these methine protons at different chemical shifts (5.18 ppm vs. 5.02 ppm) 
gradually decreases as the mol % PC increases in the copolymer, indicating the statistically 
“random” nature of the copolymerization. A summary of polymer composition is given below in 
Table 2.1. 
An important implication of employing the copolymer of LLA and PC is to lower the Tg 
of the copolymer.  PLLA is below its Tg at the physiological temperature and the incorporation 
of PC into its backbone can help reduce crystallinity and lower the Tg of the resultant copolymer. 
 
Table 2.1. Summarized polymerization data for P(LLA-co-PC) copolymers. 
PC Loading 
(%PC)a 
%PC 
Incorporationb 
Mn (kDa)c Mw (kDa) 
0  0 66.7  93.7  
10 6.4 53.0  57.8 
20 13.5 28.7  46.6  
25 21.05 23.0  35.8  
30 25.9 18.6  33.5  
40 32.1 15.5  23.3  
50 44.6 13.5  22.6  
75 64.1 10.5  12.4  
90 80 9.1  11.3  
100 100 5.2  9.4  
a Copoymers of LLA and PC, denote by the % loading of PC during polymerization 
b Incorporation measured by H1 NMR 
c Measured by GPC with THF eluent 
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This provides a route for altering the crystallinity and helping to make the copolymer less brittle. 
This will allow for improved mechanical properties to be observed under physiological 
conditions and in turn, helping to raise flexural strength of future composites in vivo.
31,40
  To 
demonstrate the impact on the Tg of the copolymer by the introduction of PC into PLLA, DSC 
traces of three polymers with different mol% incorporation of PC were obtained and compared 
(Figure 2.6).  
 It is clearly observed that the Tg decreases with the increased PC content.  Specifically, 
the Tg drops from 57.9 ºC for PLLA, to 53.7 ºC for P(LLA-co-PC)(AS)6.4%, and finally to 52.8 
ºC for P(LLA-co-PC)(AS)21%. The amorphous nature of the PC monomer helps to influence Tg 
by altering chain rigidity and hindering the chain’s ability to pack effectively. 
 
 
Figure 2.6 DSC Traces and physical appearance of polymers.  Left: Images of several polymers to 
demonstrate changes in physical appearance caused by changes in polymer chain length and distribution. 
Right: DSC traces for three of these polymers are given to demonstrate the tunability of Tg as a function 
of increased %PC content on the polymer backbone.   
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Since both the HAp and enTMOS portions of the composite are very brittle, addition of a 
rubbery copolymer can help improve polymer tensile strength by increasing flexibility and 
elongation at break within the composite.14  
PLLA and high PLLA content polymers appear as white fibrous solids at room 
temperature (0 – 10% PC incorporation) due to the high LLA content.  As the mol% PC 
increases in the polymer, MW decreases and polymers becomes slightly more yellow in 
appearance, less fibrous and softer.  Above 50 mol% PC incorporation, the polymers appear as 
viscous yellow/orange liquids.  These polymers are largely amorphous due to the high PC 
content in the backbone, which serves to add steric bulk, reduce symmetry, and lower rigidity 
when compared with LLA segments.  The short chain length of these polymers also obstructs 
effective packing and crystallization of adjacent chains.  Examples of the physical appearance of 
several polymers are also given in Figure 3 for reference. 
2.4 Post-Polymerization CuAAC Click Functionalization and Amalgamation  
After determining that PC can successfully copolymerize with LLA to give polymers 
with controlled composition and properties, it was important to functionalize the pendant 
acetylene of PC to help understand how this functionalized polymer can be processed into HAp-
Gemosil composites.  CuAAC (a “Click” reaction) allows nearly quantitative coupling of 
terminal azides to alkynes via Cu(I) catalysis, with few byproducts and little purification 
needed.41  This approach was attempted for several PC functionalized copolymers and coupling 
was observed to be successful.10,42  This reaction is highlighted in Figure 2.7 
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Figure 2.7 Post-polymerization functionalization of P(LLA-co-PC) with AS via CuAAC “Click” 
reaction 
 
However, after the CuAAC reaction, the recovery of polymer after attempted removal of 
residual copper catalyst proved difficult without initiating minor cross-linking of the grafted AS 
backbone groups. This cross-linking and subsequent loss of solubility confirmed the coupling 
reactions were successful. Fortunately, complete gelation was not observed for polymers with 
low mol %PC (<45%), due to the low density of AS on the backbone. However, the AS 
functionalized polymers showed poor solubility in PBS buffer and as-formed composites (i.e., 
copolymer mixed with HAp-Gel) showed poor properties after setting. To remedy this, 10% 
acetone in PBS buffer was used to facilitate dissolving P(LLA-co-PC)(AS) and subsequent 
blending the polymer with HAp-Gel to create a more homogenous composite. More importantly, 
using this two-solvent processing, the partially soluble white powder formed after CuAAC can 
now be further reacted through these un-crosslinked, free alkoxysilyl groups with another silane 
containing cross-linking reagent, enTMOS, for better setting. The use of enTMOS allows rapid 
condensation of trialkoxy silanes, to rapidly form a strong cross-linked composite. In our 
investigation, this functionalized polymer powder is finely ground with HAp-Gel and blended 
with enTMOS, allowing enTMOS to bond to free siloxane groups of P(LLA-co-PC)(AS). This 
reaction incorporates the newly prepared copolymer into the composite siloxane matrix through 
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enTMOS.  This multiple crosslinking via enTMOS creates a fully linked gel which can be easily 
formed and allows for chemical linking of polymer to HAp-Gel to enTMOS, increasing long 
range adhesion and strength. This composite formation and subsequent sol-gel condensation 
between enTMOS and AS is highlighted in Figure 2.8.  
 
 
 
 
 
Figure 2.8 Illustration of amalgamation with HAp-Gel and condensation reactions with 
enTMOS leading to fully set composite 
 
After successfully forming these new composites with our designed copolymers 
incorporated, it was important to see how these newly formed P(LLA-co-PC)(AS) composites 
compared to other previously tested materials. To this end, we carried out the cellular and 
mechanical studies to determine the effect that polymer blending has on composites when 
compared with previously studied HAp-Gemosil samples. Figure 2.9 presents the results of the 
21 day MTS assay, It can be seen from these data that, when compared with the control sample, 
both previous HAp-Gemosil and new HAp-Gemosil/P(LLA-co-PC)(AS) composites showed 
similar biocompatibility over a 21 day period. Furthermore, the resultant growth curves of 
MC3T3-E1 cells were similar for all three groups. Cells grew up to 7 days and, then, leveled out. 
This indicates proliferation of cells until reaching they are able to saturate the material. At this 
point, the number of cells stays relatively constant, demonstrating no substantial leaching of 
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toxic materials out of the composite over the 21 day time interval. There were no differences in 
absorbance between the materials and the control, showing no difference in cell viability among 
the tested substrates. 
 
 
  
Figure 2.9 MTS Assay of 
Control compared to HAp-
Gel and HAp-Gel- P(LLA-co-
PC)AS 13.5% Composites 
showing cell viability. Cells 
were plated in 96 well plates 
and viability was measured 
by formazan absorbance at 
Days 1, 7, and 21 
 
 
 
 
These data suggest that the incorporation of P(LLA-co-PC)(AS) had little to no negative effect 
on the biocompatibility of HAp-Gemosil composites, and that both materials behaved quite 
similarly to the control samples with no plated material. 
As previously mentioned, HAp-Gemosil composites lacked sufficient flexural strength 
for use in orthopedic applications. The incorporation of a cross-linkable polymer was expected to 
help improve long range interaction within the composite. As presented in Figure 2.10, the 
higher flexure strength of HAp-Gemosil/P(LLA-co-PC)(AS) composites than that of the original 
HAp-Gemosil indicates an effect of fiber bridging coming from the blended long chain 
copolymers. In fact, the polymer containing composites demonstrated an increase in flexural 
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strength of nearly 40% compared to HAp-Gemosil composites. On average, flexural strength of 
HAp-Gemosil 
 (41± 9 MPa) increased for HAp-Gemosil/P(LLA-co-PC)(AS) (58± 14 MPa). 
 
 
 
 
 
Figure 2.10 Changes in biaxial flexure 
strength between HAp-Gemosil and 
HAp-Gemosil doped with P(LLA-co-
PC)AS13.5% co polymers. 
 
 
 
 
 
The stiffness of the force-displacement curve recorded from the biaxial bending test did 
not differ (P=0.08) between the original (2.06 N/mm) and the new (2.15 N/mm) composites. In 
our in-house data, the HAp-Gemosil had a compressive modulus around 862±129 MPa and a 
reduced modulus 18.0±4.9 GPa measured by the nanoindentation tester (Hysitron Inc.) Based on 
the stiffness data, we expect that the new composite might have similar modulus values although 
future tests are required. 
Though the results from initial biocompatibility and mechanical tests are promising, this 
polymer system presents several key limitations. Primarily, the sensitivity of the P(LLA-co-
PC)(AS) lead to premature cross-linking of polymer bound silanes. This in turn made complete 
blending of composite cements with the polymer more difficult. This presented multiple negative 
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consequences when dealing with this HAp-Gemosil/P(LLA-co-PC)(AS) bioceramic composite. 
Primarily, this limitation can influence reproducibility and utility of composites like those tested 
in this study. The use of a second, less polar solvent (acetone) during blending helped improve 
composite formation, making it possible to study the interaction of this polymer within HAp-
Gemosil composites. Unfortunately, the use of organic solvents removes our ability to dope this 
composite with cells for scaffolding applications, and these processing issues hinder the ability to 
study composite interactions in vivo. Furthermore, this second solvent helped blend phases 
during processing, but ultimately did not solve all problems associated with blending a 
hydrophobic inorganic ceramic (HAp-Gel) with a hydrophilic polymer phase (P(LLA-co-
PC)(AS). This mismatch manifested itself in displaying poor interfacial adhesion between 
components. Although this was still able to provide considerable fiber bridging and improved 
flexural strength, it led to a large decrease in compressive strength when compared to HAp-
Gemosil, showing in Figure 2.11.Though HAp-Gemosil did not possess the compressive 
strength of natural 
bone, it was 
sufficiently close for 
consideration.  
 
 
 
Figure 2.11 Changes in 
compressive strength 
observed between HAp-
Gemosil and HAp-
Gemosil doped with 
polymer, compared to 
natural cortical bone. 
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However, the large decrease seen in polymer doped samples makes it insufficient for 
consideration as a load bearing material for orthopedic applications, further complicating this 
materials ability to be used for potential scaffolding applications. 
Despite the drawbacks, this system still showed merit in improving some properties of 
HAp-Gemosil composites, while preserving their biocompatibility. Improvements in cross-
linking chemistry are required to allow for better processability and material performance. These 
improvements would allow this system to be more rigorously studied in vivo to determine the 
efficacy of this polymer/ceramic system for future scaffolding applications.  
2.5. Conclusions 
In summary, we have synthesized a derivatized TMC monomer, PC, which is capable of 
undergoing ROP with L-Lactide to afford copolymers with tunable MW, mol % PC 
incorporation and Tg. The ability of these monomers to copolymerize and yield potentially 
biodegradable and biocompatible polymers of tunable properties makes this an attractive system 
for biological applications. In the current demonstration, we coupled the copolymer with AS 
graft agents inspired by enTMOS, converting the copolymer into “cross-linkable” via these 
pendant silane groups. After being processed into the original HAp-Gemosil cement composite 
facilitated by the amino-silane enTMOS, these AS functionalized polymers were capable of 
bridging the new composite and providing enhanced long range adhesion, while still maintaining 
the biocompatibility of the new composite. 
The current grafting approach did have some key limitations, however. Notably, the 
sensitivity of polymer bound silanes prevented extensive purification after CuAAC coupling. As 
a result, some residual copper from CuAAC was generally trapped in the composite after 
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coupling, which could lead to the possibility of increased cell morbidity. Furthermore, the 
premature cross-linking could contribute to an inability of these polymers to fully cross-link into 
the enTMOS silsesquioxane matrix, leading to poor adhesion between the hydrophobic polymer 
and the hydrophilic HAp-Gel moieties in the composite. Therefore, further work remains to be 
done, especially regarding the graft monomer and cross-linking. Fortunately, the PC monomer 
introduces a pendant acetylene group on the copolymer, which provides a synthetic handle for 
post-polymerization modification to give more synthetic freedom.  This ‘acetylene handle’ 
allows various pendant groups to be attached to the copolymer, thus one can further alter the 
composite properties to obtain unique, applications specific properties.  Future composites will 
be synthesized using similar P(LLA-co-PC) polymers as the chemistry and properties of these 
copolymers have been elucidated in this study, but emphasis will be placed on utilizing alternate 
“click” reactions which can  preclude the use of potentially toxic catalysis.  Alternate graft 
monomers will also be investigated to determine a method for cross-linking which can be easily 
degraded.  This will eliminate potential problems caused by residual material left after 
degradation.  Additionally, a less sensitive method of cross-linking would be ideal as to allow 
better control of cross-linking reactions and thereby improve processing of the final composite. If 
these issues can be sufficiently addressed, this HAp-Gemosil-P(LLA-co-PC)(AS) copolymer 
system will provide a new springboard to undertake further scaffolding composite work. 
2.6 Experimental Details  
General Methods 
 All moisture sensitive reactions were performed in flame-dried glassware under an 
atmosphere of Ar. Reaction temperatures were recorded as external bath temperatures. The 
phrase “concentrated under reduced pressure” refers to the removal of volatile materials by 
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distillation using a Büchi rotary evaporator at water aspirator pressure (< 20 torr) followed by 
removal of residual volatile materials under high vacuum (< 1 torr). The term “high vacuum” 
refers to vacuum achieved by a standard belt-drive oil pump (< 1 torr). 
1H and 13C NMR spectra were recorded on Bruker AC-400 (400 MHz) spectrometers. 
Chemical shifts are reported in parts per million (ppm) relative to residual solvent peaks (CHCl3: 
1H: d 7.26). Peak multiplicity is reported as: singlet (s), doublet (d), triplet (t), quartet (q), 
multiplet (m), and broad (br).  
Materials  
Ethyl chloroformate (99%) and CaH2 (60% in mineral oil), and 4-tert butyl benzyl 
alcohol (98%) were obtained from Acros Organic and used as received. 1,1,1-Tris(hydroxyl 
methyl)ethane (THME, 99%), triethylamine (TEA, 99%), 5-bromovaleryl chloride (98%) and 
CuBr (98%) were obtained from Alfa Aesar and used as received.  Benzaldehyde (Aldrich 98%), 
p-toluene sulfonic acid (TsOH, Aldrich, 98.5%), (N, N’-bis [(3-trimethoxysilyl)propyl]ethylene 
diamine (enTMOS, 95% in MeOH, Gelest), tin(II) 2-ethyl hexanoate (SnOct2 98% MP 
Biomedicals), propargyl bromide (80% in toluene, TCI) and 3-aminopropyl trimethoxy silane 
(96% TCI) were used as received. L-Lactide was generously donated by Purac and used without 
further purification. Hexanes, acetone, chloroform, dichloromethane (DCM), anhydrous toluene, 
anhydrous methanol (MeOH), ethyl acetate and tetrahydrofuran (THF) were obtained from 
Fisher. THF was freshly distilled over sodium before use.  
Synthesis of (Propargyl Carbonate (PC)) Monomer 
Synthesis of PC monomer is adapted from previously reported work by Chen et al.39  A 
typical synthesis of PC is presented and outlined in Figure 2.1.  THME (26 g, 0.217 mmol) and 
TsOH (1.2 g, 6.3 mmol) were dissolved in anhydrous THF (400 mL) and stirred at room 
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temperature.  To this stirring solution, benzaldehyde (23.2 mL, 0.23 mmol) was added dropwise 
and allowed to react for 16 hours.  The reaction was then neutralized with aqueous ammonia and 
concentrated by rotary evaporation.  The product was then dissolved in DCM and washed 3 
times with water before again concentrating under rotary evaporation to yield 39 g (94%) of C1 
as a colorless solid.  1H NMR (400 MHz, CDCl3): δ 0.81 (s, 3H), 3.66 (d,2H), 3.91 (s, 2H), 4.06 
(d, 2H), 5.44 (s, 1H), 7.35-7.49 (m, 5H).  
C1 (35 g, 168 mmol) in THF (50 mL) were added dropwise to a cold stirring solution of 
NaH (60% in mineral oil, 12 g, 302 mmol) at 0 ºC to yield a milky white solution.  After 30 
minutes of cold stirring, the solution was heated on oil bath to 60 ºC for 2 hours, yielding a pale 
yellow solution.  Propargyl bromide (25 g, 211 mmol) was then added dropwise and allowed to 
stir for 16 hours.  This solution was then quenched with water to afford a deep red solution with 
precipitate.  This solution was extracted 3 times with brine and concentrated under high vacuum 
to yield crude C2 as a red oil.   
Crude C2 (12 g, 48.7 mmol) was stirred in 400 mL 1:1 v/v MeOH:1M HCl for 2 hours. 
1M NaOH was then used to raise the pH to 7 before MeOH was removed by rotary evaporation.  
The product was extracted using ethyl acetate to yield crude C3. Purification via flash 
chromatography using 2:1 ethyl acetate: hexanes yielded 6.1g (54% over 2 steps) C3 as an 
orange oil.  1H NMR (400 MHz, CDCl3): δ 0.84 (s, 3H), 1.65 (b, 2H) 2.45 (s, 1H) 3.49 (s, 2H) 
3.58(d, 2H), 3.67(d, 2H), 4.15(s, 2H) 
C3 was dissolved (5.18 g, 32.7 mmol) with ethyl chloroformate (6.68 g, 65 mmol) in 
THF (300 mL).  Triethyl amine(7.1 g, 65 mmol) was then added to this stirring solution 
dropwise and allowed to react for 4 hours.  Water was then used to quench the reaction slowly 
and the reaction was washed with brine.  The organic layer was then concentrated by rotary 
 46 
evaporation and then purified via flash chromatography with 2:1 hexanes: ethyl acetate to yield 
4.52 g (75%) Propargyl Carbonate (PC).  1H NMR (400 MHz, CDCl3): δ 1.11 (s, 3H) 2.46 (s, 
1H), 3.49(s, 2H), 4.07 (d, 2H), 4.17 (s, 2H) 4.33 (d, 2H).  13C NMR (400 MHz, CDCl3) δ 17.26, 
32.8, 58.7, 70.66, 73.81, 75.25, 78.83, 148.17 
Synthesis of Graft Monomer: 5-azido-N-(3-(trimethoxysilyl) propyl) pentanamide (AS) 
Synthesis of AS is shown in Figure 2.2. To a dry flask, (3-aminopropyl)trimethoxysilane 
(1.44 g, 8 mmol) were dissolved in THF with TEA (1 g, 10 mmol) and set to stir (clear solution).  
5-bromovaleryl chloride (2 g, 10 mmol) was then added dropwise, forming a white precipitate. 
This solution was allowed to react for 16 hours under argon.  The solution was subsequently 
filtered to remove the salt and concentrated by rotary evaporation to yield 2.73 g (99%) G1 
without further purification.  1H NMR (400 MHz, CDCl3): δ 0.65 (q, 2H), 1.63 (p, 2H), 1.80 (m, 
4H), 2.19 (t, 2H), 3.24 (t, 2H) 3.4 (t, 2H), 3.57 (s, 9H), 5.65 (b,1H) 
G1 (2.73 g, 8 mmol) was then dissolved in anhydrous DMF and added to NaN3 under dry 
conditions. This was allowed to react for 16 hours under argon atmosphere. DMF was then 
removed under vacuum for 36 hours before dry EtOAc was used to extract AS and the 
compound was again concentrated to yield pure AS 2.4 g (98%) which was stored under dry 
conditions in a glovebox.  1H NMR (400 MHz, CDCl3): δ 0.65 (t, 2H), 1.78 (m, 6H), 2.19 (t, 
2H), 3.26 (m, 4H), 3.41 (s, 9H), 5.69 (s, 1H).  13C NMR (400MHz, CDCl3) δ 6.46, 22.68, 22.81, 
28.34, 35.83, 41.77, 50.45, 51.09, 172.27  
Synthesis of Copolymers by Sn(Oct)2 Catalyzed ROP 
PC monomer was purified by flash chromatography and its purity was verified by NMR 
analysis.  The monomer was dried over CaH2 before use.  Polymerization was carried out in 
toluene at 120 ºC for 20 hours using 4-tert-butylbenzyl alcohol as the initiator and stannous-2-
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ethyl hexanoate (Sn(Oct)2) as the catalyst as shown in Figure 2.3. The ratio of monomers to 
catalyst to initiator was 100:1:1 [M]:[C]:[I] for all polymerizations.   The following is a typical 
synthesis for copolymer with 10 mol% PC loading.  In a glovebox under argon atmosphere, LLA 
(7 g, 48 mmol) and PC (0.884 g, 4.8 mmol) were added to a high pressure flask with 10 mL 
anhydrous toluene.  To this solution, Sn(Oct)2 and 4-tert-butylbenzyl alcohol (0.075 M, 7 mL) 
were added quickly and the vessel was then sealed.  The reaction container was quickly 
transferred to an oil bath outside of the glovebox and allowed to react for 20 hours before 
quenching with methanol.  The resulting polymer P(LLA-co-PC) was isolated by precipitation 
into cold MeOH, and further purified by precipitation from the DCM solution of the polymer 
into cold methanol 3 times.  NMR analysis revealed this polymer to contain 6.4 mol% PC in the 
backbone and thus was denoted as P(LLA-co-PC) 6.4% for clarity. 
Characterization of Polymers 
The monomer incorporation ratio of all copolymers was determined using a Bruker 
spectrometer (400 MHz).  CDCl3 was used as the solvent and the chemical shifts were calibrated 
against residual solvent signals.  The molecular weight and polydispersity of the copolymers 
were determined by a Waters 1515 gel permeation chromatograph (GPC) using THF as the 
eluent at a flow rate of 1.0 mL/min at 30 ºC.  A series of narrow polystyrene standards was used 
for the calibration of the columns. Thermal behavior was investigated using a TA Q100 
differential scanning calorimeter (DSC) under nitrogen atmosphere.  All samples were scanned 
from – 10 ºC to 200 ºC at 10 ºC/min before being quenched with liquid nitrogen.  The samples 
were then rescanned from – 10 ºC to 200 ºC and data were collected. Glass transition (Tg) was 
taken as the midpoint of heat capacity change and crystallization (Tc) and melting (Tm) were 
shown by exo- and endo-thermal peaks, respectively. 
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Post Polymerization Modification of Polymers via CuAAC 
CuAAC reactions were performed in anhydrous DMF at room temperature under argon 
atmosphere.  A typical synthesis of P(LLA-co-PC) 6.4% follows.  The azide containing linking 
monomer (AS), was dissolved with P(LLA-co-PC) 6.4% and CuBr in DMF.  Load ratios of AS 
to acetylene groups of the polymer were 1.1:1 (slight excess of AS) and CuBr was loaded at 2 
mol%.  Elemental copper was added in trace amounts to help stabilize Cu(I) ions in solution.  
This reaction is allowed to run for 2 hours before precipitation in cold MeOH to yield white 
powder of AS functionalized polymer P(LLA-co-PC)(AS) 6.4%. Polymers were treated with 
EDTA prior to precipitation in methanol to help remove excess copper catalyst.  
Amalgamation of AS Functionalized Polymer 
Composite cement materials were prepared for biaxial flexure and biocompatibility 
testing using P(LLA-co-PC)(AS)13.5% loaded at 10wt% into the composite A typical composite 
formation is presented here with 10 wt% copolymer in the composite.  HAp-Gel (250 mg), 
prepared as previously reported25, was mixed with P(LLA-co-PC)(AS)13.5% (25 mg) and the 
blend was ground into a fine powder. Next, 100 μL of enTMOS (95% in MeOH) was added to 
the powder and mixed thoroughly.  To this mixture, a 10% acetone in PBS solution (420 μL) was 
added while gently kneading the composite into a clay.  This clay was then formed into a mold 
and pressed to remove excess solvent.  It was left for a minimum of 72 hours at room 
temperature to dry.  This procedure was repeated for all composites.  After drying, a solid 
material was obtained which could be trimmed and used to test the material’s flexural strength.  
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Figure 2.12 Biaxial 
flexure test apparatus. 
Biaxial flexure strength 
The testing procedure for biaxial flexure strength was 
performed according to Ban and Anusavice.43  Four sample disks 
(diameter 10 mm by thickness 1mm) of each group (HAp-Gemosil 
and HAp-Gemosil/P(LLA-co-PC)AS 13.5%) were prepared in 
Teflon molds.  The upper and lower surfaces were polished in 
order to obtain parallel surfaces with no apparent defects.  After 
measuring the sample diameter (d) and thickness (t), the disk was 
supported on three stainless steel balls (3mm in diameter), which 
were equally spaced along a 3.25mm radius (rs).  Prior to testing, 
a stainless steel piston (radius = rp=1.5mm) was aligned concentrically with the three balls 
(Figure 2.12).  A crosshead speed of 0.5mm/min was used, and the maximum force at failure (P) 
was determined using an Instron 4411 Machine (model 4411, Instron Co., Norwood, MA).  A 
Poisson’s ratio (ν) of 0.3 was used for both materials. The flexure stress at failure (σ in MPa) was 
calculated using the following expressions: 
σ = /   
and A = 

π [21 +  ν ln 

 + 1 −  ν2 −  2()
 + 1 + ν] 
where      = 1.6 +  

 − 0.675 
 
Viability test: Preosteoblast cell proliferation by MTS Assay 
The 6-well transwell plate (Corning Transwell-Clear Permeable Supports) was used for 
cell proliferation testing. The material disc (diameter 15mm by thickness 1mm) was placed on 
the permeable membrane support of the transwell, which allowed materials immersed in the 
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culture medium. The 1 × 10-5 Preosteoblasts MC3T3-E1 were seeded to each well. Every three 
days, the medium was replenished with 2ml fresh growth medium (α-Minimum Essential 
Medium with 10% fetal bovine serum and 1% penicillin and streptomycin).  At the end of 
cultivation (1, 7, and 21 days in culture), the disk and the permeable support were removed. 40 
µL of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-
tetrazolium salt (MTS) reagent (Promega, Madison, WI USA) was added to each well containing 
400 µL of αMEM, and the plate was incubated for 1 hour at 37°C under a humidified atmosphere 
of 5% CO2.  From each well, 100 µL of the mixed solution was transferred into well of a 96-well 
plate.  Each well was triplicated.  The absorbance of each well at 490 nm was measured using a 
microplate reader (Microplate Reader 550, Bio-Rad laboratories, Philadelphia, USA).  Relative 
cell numbers were quantified on the basis of the concentration of the formazan product of MTS. 
Three samples will be used at each time point for each material group. Three experimental 
groups of materials were investigated, including Gemosil, Gemosil/P(LLA-co-PC)AS 13.5%, 
and dishes as received without coating (control).  
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CHAPTER 3: THE ROLE OF TEMPERATURE IN FORMING SOL-GEL 
BIOCOMPOSITES CONTAINING POLYDOPAMINE  
 
In the previous chapter, the utility of adding polymers to bioceramics was discussed. In particular, 
a novel bioceramic composite known as HAp-Gel was introduced, and its physical properties were 
improved by the addition of a tri-alkoxy silane cross-linker. However, despite the numerous favorable 
properties, further improvements were required. The addition of copolymers to these composites was able 
to improve flexural strength of these materials and increase their potential for future clinical applications. 
Copolymers envisioned to mimic the role of collagen in natural bone, and were designed based on 
the physical properties of their homopolymers. L-Lactide was chosen for its established biocompatibility, 
good mechanical properties, and established use in bioceramic materials. To compliment this monomer, a 
trimethylene carbonate derivative was also synthesized to provide a synthetic handle through which the 
copolymer can be incorporated into the composite to help improve long range order, mimicking the role 
of collagen in natural bone. Furthermore, this monomer also served to help tune properties in the 
copolymer to improve composite performance.  
While substantial improvements were made in regards to ultimate tensile strength, without 
compromising biocompatibility and processability of these polymer containing composites, difficulties 
were also encountered. Specifically, the utilization of a hydrophobic polymer in conjunction with a 
hydrophilic bioceramic HAp-Gel led to a loss of compressive strength caused by poor interfacial adhesion 
between the HAp and polymer phases. Though the polymer was able to mimic some aspects of collagen 
in natural osseous tissue,  the poor adhesion to the rest of the composite necessitated improvements in the 
polymeric component of these materials.  
 56 
 In the following chapter, a logical extension of the chemistry described in Chapter 2 will be 
discussed. Since the addition of polymers was able to help performance of these composites, and 
problems were encountered through poor adhesion, this chapter aims to utilize polymers with better 
adhesive properties in HAp-Gel composites. In this way, it is believed that the favorable aspects of 
polymeric blending would be maintained, without the loss of strength due to poor adhesion between 
inorganic and organic constituents of the composite.  
3.1. Motivations and Background on HAp-Gel and Polydopamine Containing Materials 
Our previous study has demonstrated the ability of HAp-Gel to provide a suitable substrate 
for osteoblast attachment, growth, and subsequent osteogenesis.1 These composites, however, 
were shown to require cross-linking from bis[3-(trimethoxysilyl)-propyl]ethylenediamine 
(enTMOS) to increase strength.2 These composites, termed as HAp-Gemosil (i.e., 
hydroxyapatite–gelatin modified with siloxane), successfully showed improved compressive 
strength and processability without sacrificing biocompatibility or osteoconductivity. 
Unfortunately, the inclusion of the enTMOS network resulted in composites which were still too 
brittle for in vivo use. Prior work with bioceramics has shown that the incorporation of polymer 
chains into the ceramic matrix can help improve mechanical properties and strength of these 
composites, as well as in vivo and in vitro biocompatibility.3 This trend was also observed in a 
modified HAp-Gemosil composite utilizing a biodegradable polymer based on L-lactide to 
improve the flexural strength.4 Though the flexural strength was indeed increased, the polymer 
toughened HAp-Gemosil composites were plagued by poor adhesion between the hydrophilic 
HAp-Gel and the hydrophobic polymer, leading to a loss in the compressive strength. Good 
adhesion between components of a blend is necessary in order to maintain good mechanical 
properties and avoid creating internal loci which are prone to mechanical failure.5 The results 
obtained by investigating HAp-Gemosil and similar composites with polymers included highlight 
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the need for alternative polymers and cross-linking routes, in order to further improve important 
application related properties of these composites.  
Recently, investigations into the adhesive properties of several sessile marine organisms have 
identified a series of proteins from mytilus edilus which demonstrate remarkable adhesion to a 
wide range of substrates.6 Inspired by fact that these proteins are rich in 3,4-dihydroxy-L-
phenylalanine (DOPA) and lysine amino acids (amine), Messersmith and co-workers 
hypothesized that dopamine, a small molecular that contains both functionalities (DOPA and 
amine), could structurally mimic these complex proteins and offer similar adhesion behavior. 
Indeed, the same authors experimentally confirmed that dopamine undergoes self-polymerization 
under basic conditions to form polydopamines (PD),7 which can form thin polymer coatings 
adhering to a variety of organic and inorganic materials. Similar polymerization behavior of 
dopamine and the excellent adhesion of PD to numerous materials have been further 
demonstrated by others,5 though the structure of PD is not well understood.8,9 Since composites 
utilizing PD are formed from a homogenous dispersion containing dopamine, this polymerization 
can potentially introduce a new interconnected polymer network. This newly formed polymer 
network can serve to connect distal portions of the composite, which can serve to increase long 
range interactions within a material. The combination of forming a polymer and increasing 
adhesion can potentially increase both long and short range interactions within a composite. For 
these reasons, the complex behavior of PD, and its numerous potential applications have become 
an attractive topic of study when investigating new materials for bioceramics.10,11  
Inspired by the exciting discoveries and features of polydopamine (PD), we attempted to 
introduce dopamine into our HAp-Gemosil formulation, and re-named these new composites as 
HAp-Gemosilamine (i.e., hydroxyapatite-gelatin modified with silane and dopamine). This type 
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of composite was designed to impart the excellent adhesive properties of PD, the 
biocompatibility and osteoconductivity of hydroxyapatite, and the mechanical strength of the 
enTMOS silsesquioxane network into a single phased composite. It was believed the 
combination of these properties would yield strong, functional materials with possible future 
biological applications. A number of such HAp-Gemosilamine composites were then formulated 
and tested (Figure 1). Various processing conditions were utilized in order to thoroughly study 
the setting behavior of these materials. Interestingly, composites which were allowed to begin 
setting at depressed temperatures, – 20 °C, before finishing setting at 20 °C, showed markedly 
improved properties when compared with HAp-Gemosil. However, when these composites were 
processed entirely at 20 °C, their mechanical properties were surprisingly poor. The interesting 
discrepancies within HAp-Gemosilamine composites prompted us to conduct a careful 
investigation, which is detailed in this report. 
3.2 Forming HAp-Gemosilamine Composites: Observation and Hypothesis 
When dealing with these new HAp-Gemosilamine materials, it quickly became apparent that 
processing temperature played a critical role in forming a robust composite capable of 
mimicking the mechanical strength found in natural bone. We denote the “warm” samples as the 
composite allowed to set at room temperature (20 °C) after mixing. The “cold” samples, on the 
other hand, were allowed to set for approximately 5 minutes at – 20 °C, before subsequent 
warming to room temperature to finish setting. While this difference in processing condition 
seems minor, the large difference observed in mechanical properties of the “warm processing” 
sample and the “cold” sample clearly demonstrates the opposite (Figure 3.1). For example, the 
HAp-Gemosilamine processed under the “cold processing” condition shows a compressive 
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strength close to 100 MPa, noticeably higher than that of the HAp-Gemosil (~ 80 MPa), and 
more than doubling that of the HAp-Gemosilamine processed under the “warm” condition. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Compressive data for HAp-Gemosil and HAp-Gemosilamine processed at ‘warm’ (20°C) 
and ‘cold’ (-20°C) 
 
So what causes this interesting temperature dependence behavior? Since HAp-Gemosil 
composites did not show any processing temperature dependence on their material properties in 
our previous investigation, we believe that the newly added component, dopamine, must be 
playing a critical role in the observed temperature dependence of the mechanical properties of 
HAp-Gemosilamine. We hypothesize that while dopamine is able to polymerize uninterruptedly 
at both low temperatures and room temperature, the sol-gel reaction of silanes is significantly 
hindered at low temperatures. Therefore, when the mixture is allowed to react at – 20 °C, only 
polydopamine (PD) formation proceeds appreciably to form the PD network, whereas the sol-gel 
reaction of silanes only occurs to a negligible extent. However, the small molecule and liquid 
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nature of the enTMOS molecules can permeate the entire composite even after the “soft” PD 
network is formed. When such a composite is allowed to warm up to room temperature, 
enTMOS starts to polymerize rapidly to form the silsesquioxane matrix that can effectively 
envelope the newly formed PD network, creating a series of inter-penetrating networks based on 
both PD and silsesquioxane. Such intricate networks formed by both PD and silsesquioxane help 
to strengthen the new composite, HAp-Gemosilamine, when compared with the original HAp-
Gemosil composite. This “cold” processing, together with its effect on the formation and 
structure of the composite, is illustrated in Figure 3.2a. In contrast, when the entire composite is 
processed at 20 °C, the rate of polymerization for enTMOS is overwhelmingly faster than that of 
the dopamine polymerization. Before dopamine can form an effective network via its own 
polymerization, the polymerization of enTMOS already yields a glassy, highly cross-linked 
silsesquioxane network. Such a “hard” network will trap dopamine molecules (and oligomers of 
PD) into isolated regions. This will eventually lead to segregated PD domains within the cross-
linked silsesquioxane network, which is ultimately detrimental to mechanical properties of these 
composites.   
This scenario, i.e., the “warm” processing, is correspondingly illustrated in Figure 3.2b. In 
summary, we believe the difference in kinetics for these two reactions (i.e., polymerization of 
dopamine, and sol-gel cross-linking of silanes) and the mechanical nature of these two networks 
(i.e., soft gel of PD and hard glass of silsesquioxane network)would directly result in the 
significant difference in the micro/nano structures of these composites processed at different 
tempera tures.Such structural difference in these composites leads to the observed dramatic 
difference in the mechanical properties, as were shown in Figure 3.1. Specifically, the inclusion 
of PD in “cold” samples improves mechanical properties when compared with HAp-Gemosil 
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materials, while the inclusion of PD in “warm” samples causes a dramatic reduction in 
mechanical strength. 
 
 
Figure 3.2 (a) Illustration of polymerizations involved while HAp-Gemosilamine composites are allowed 
to set under – 20°C. While the composite is held at a cold temperature, PD is able to effectively 
polymerize, while enTMOS polymerization is suppressed. This allows an extensive, interconnected PD 
network to form before being encapsulated by the rapid gelation of enTMOS as the composite warms to 
room temperature to complete setting. (b) The situation would change when HAp-Gemosilamine 
composites are processed at 20°C. These composites polymerize enTMOS very rapidly, leading to a 
highly rigid network forming rapidly. This rigid network prevents PD from forming an extensive network, 
and ultimately creates weak spots in the material by localizing dopamine monomers and macromolecules 
into small isolated pockets. 
 
3.3 Experimental Design: Practical Considerations 
According to the hypothesis detailed above, investigating the reaction kinetics of each 
component individually should be the crucial step to experimentally elucidate their effect on 
final composite performance. This practice helps develop an understanding of how each 
component is able to work with the others to afford materials whose properties are greater than 
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the sum of their parts. Such a further understanding would be important for optimizing and 
utilizing future PD containing bioceramic composites.  
Ideally, one should investigate the polymerization behavior of one component (e.g., 
enTMOS) in the presence of the other component (e.g., dopamine) and other parts of the 
composites (e.g., HAp-Gel) to obtain the most relevant data. Unfortunately, within the newly 
developed HAp-Gemosilamine composite, several reactions are occurring between the various 
components of the material. This complication makes it very difficult to quantify the way a 
single component is behaving within the actual blend. Therefore it became necessary to simplify 
these reactions in order to more adequately characterize the behavior of a single component. For 
example, to further study how temperature can influence the progress of enTMOS sol-gel 
reactions, a series of experiments with enTMOS as the only component were carried out.  
Similarly, to study the behavior of PD in the composite, it became necessary to alter the 
conditions under which PD was made to polymerize. When preparing HAp-Gemosilamine as 
stated above, PBS buffer, Ca(OH)2, and Ammonium Persulfate (AP) were added to initiate cross-
linking of enTMOS and subsequently PD. However, the actual concentration for dopamine used 
in HAp-Gemosilamine was too high to be observed via UV-Vis spectroscopy to monitor the 
reaction progress (vide infra). Therefore, we lowered the concentration of dopamine in solution 
(rather than in an almost solid state as in actual composite) such that the absorbance of the 
solution would be at the right level to track the progress of the reaction spectroscopically. 
Finally, because the concentration was lower, the freezing point would not be depressed in a 
manner similar to what we observed during processing of HAp-Gemosilamine. For this reason, it 
also became necessary to change solvents from water to methanol, otherwise the entire water 
based solution of such a low concentration would have been frozen at – 20 °C. This allowed our 
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“cold” experiments to also be modelled in a manner similar to the way the “warm” samples 
were. Additionally, for solubility reasons, Ca(OH)2 was replaced with NaOH and AP was not 
used. AP was omitted to try to keep the reaction from happening too rapidly10, thereby giving us 
more time to monitor the reaction progress and to draw meaningful conclusions from our data.  
Although these experiments do not exactly mimic the behavior and environment of enTMOS 
and dopamine within a composite, these data can help illuminate the observed inconsistencies 
between 20 °C and – 20 °C HAp-Gemosilamine samples.  
3.4 Temperature Dependence of The Sol-Gel Reaction of enTMOS 
Typically, enTMOS sol-gel polymerizations begin to cross-link and solidify within minutes 
after initiation at room temperature. Therefore, for a HAp-Gemosilamine composite at 20 °C, the 
sol-gel reaction of enTMOS occurs rapidly as methanol is removed and an insoluble, glassy 
composite remains. As a result, this brittle silsesquioxane matrix sets the composite within 
minutes, effectively blocking further appreciable molecular diffusion. The final weight of this 
glass is roughly 70% of the initial enTMOS loading, due to the loss of methanol through 
hydrolysis condensation reactions.  
However, this sol-gel reaction of silanes has shown little spectroscopic difference as the 
reaction proceeds, making it difficult to spectroscopically track the reaction progress in the 
studied range of 20 °C and – 20 °C. Fortunately, the insolubility of this newly formed 
silsesquioxane gel allowed us to design a mass loss-based method to monitor the progress of this 
reaction. Specifically, by washing out the soluble portions of enTMOS (e.g., monomers and 
oligomers) at various time intervals, it would be possible to track how this reaction proceeds over 
time and determine what role temperature plays in this cross-linking polymerization. For 
example, if the reaction had not proceeded appreciably, nearly all of the initial enTMOS 
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monomers and non-cross-linked oligomers would be washed away, showing a very high mass 
loss. Conversely, if the reaction had been already in an advanced stage and highly cross-linked, 
almost no monomers and oligomers would be removed by washing, showing a very low mass 
loss. By determining the time point at which the cross-linking reaction begins and ends at 
suppressed and elevated temperatures, we can gain a better understanding on how the reaction is 
likely proceed within the much more complex composite (e.g., HAp-Gemosilamine).  
Figure 3.3 presents the results from these mass loss experiments. These data clearly 
demonstrate that at – 20 °C, the sol-gel reaction enTMOS is retarded for tens of minutes, and 
these “cold” composites do not begin setting appreciably until after several hours.  
 
 
 
 
Figure 3.3 Mass loss data 
for enTMOS 
polymerizations. Samples 
which have reacted 
extensively will show very 
high mass loss, since 
these samples are highly 
cross-linked and their 
polymers are insoluble. 
This phenomenon is 
observed for the enTMOS 
samples processed at 20 
°C. It can be clearly seen 
that the opposite trend 
exists for enTMOS 
processed at – 20°C, 
where very little material 
has reacted even after 3 
hours. 
 
In contrast, this retardation is not observed for the same sol-gel reaction at 20 °C. Over the same 
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dependence on temperature of this sol-gel reaction implies that when processing these 
composites with multiple components (e.g., HAp-Gemosilamine) at room temperature, the rapid 
polymerization of enTMOS would cause the composite to begin setting quickly at early stage. 
Afterwards, all reactions within the composite would become heavily diffusion controlled. This 
diffusion control can hinder the ability of other reactions to take place during the final setting of 
the composites. The interruption of these other reactions, such as dopamine polymerization, can 
lead to incomplete setting and poor mechanical strength. Apparently, lowering the temperature to 
slow down the sol-gel reaction of enTMOS would allow ample time for all desirable reactions to 
occur synergistically, resulting in a proper setting of the composite with improved mechanical 
strength.  
3.5 Temperature Dependence of Dopamine Polymerization 
Fortunately, unlike the enTMOS gelation, it is possible to use spectroscopy to monitor the 
progress of dopamine polymerization because the oxidation of dopamine to form the PD is 
accompanied by a characteristic color change. As more monomers become oxidized and 
subsequently polymerize, the solution turns darker. This is likely caused by increased pi-pi 
interactions within the newly forming macromolecules. According to the work of Wei et al.,10 
the PD formation can be monitored using UV-Vis spectroscopy at 350 nm. This offers us a 
simple method for monitoring the formation of PD and is indicative of the extent of PD 
polymerization by comparing the intensity of the UV-Vis absorption at different time intervals. 
Though this does not give us a quantitative measure of dopamine’s degree of polymerization, it 
gives us useful information about how this polymerization is progressing under a certain set of 
conditions.  
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In practice, we simplified the system to contain only dopamine, methanol, and NaOH. This 
simple system still retains the essence of the polymerization of dopamine to PD; more 
importantly, such a diluted system allows for visualizing and comparing the reactions progress in 
solution by the UV-Vis absorption. We then conducted these experiments for samples at both – 
20 °C and 20 °C and the results are highlighted in Figure 3.4.  
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Figure 3.4 Progress of dopamine polymerization under oxidative conditions over time. Dopamine 
was polymerized at both 20°C and -20°C. Over this temperature range, it can clearly be seen that the 
polymerization of dopamine is relatively unaffected.  
 
It can be seen clearly that, while temperature does influence PD formation, this difference on 
reaction progress at each time interval is small between – 20 °C and 20 °C. Overall, these results 
support our hypothesis that the formation of PD is much less influenced by the temperature, 
showing significantly different reaction kinetics than that of enTMOS reactions (Figure 3.3). 
In the new multi-component based composite – HAp-Gemosilamine, delaying the onset of 
the enTMOS gelation at low temperatures affords the composite has more time for the other 
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components to react more fully before being encapsulated within the new enTMOS 
silsesquioxane network and completely set. Specifically, the slowed gelation of enTMOS at low 
temperatures gives a brief time window where dopamine can polymerize relatively unhindered. 
Though the true mechanism of the formation of PD is still under debate, the work of Hong et al.8 
suggests that the polymerization of dopamine could yield regions of trimers and tetramers which 
are able to stack through pi-pi interactions.8 These small aggregates of trimers and tetramers can 
act effectively as weak cross-links between different PD chains, increasing the overall strength of 
the composite. After this initial cold setting phase, the composite is warmed up and enTMOS is 
able to then fully polymerize around the connected PD network, encapsulating it within a glassy 
silsesquioxane network. Therefore the adhesive ability of PD, and the subsequent formation of 
these interpenetrated polymer networks is key to the observed enhanced mechanical properties of 
the composite (Figure 3.1).  
3.6 Biocompatibility: MTS Assay 
Though dopamine is found naturally in the human body, its properties as a bulk material 
outside the brain are not well understood. Because the new composite HAp-Gemosilamine 
showed improved mechanical properties than those of the original HAp-Gemosil under 
appropriate processing condition, it was important to verify that using PD as a component in 
HAp-Gemosilamine would not negatively impact the biological compatibility. MTS assays were 
then carried out to determine cell viability over a 21 day period. The growth of preosteoblasts 
(MC3T3-E1) on three variant surfaces was shown in Figure 3.5. Interestingly, during the first 5 
days, the cells were sporadic and did not spread in HAp-Gemosil. In contrast, adding PD 
appeared to increase initial cell growth in the same period of time. After day 7, there were no 
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statistical differences in cell numbers among three groups, indicating excellent biocompatibility 
of the new composite HAp-Gemosilamine and warranting further investigation. 
 
 
 
 
Figure 3.5 Results 
of MTS assays of 
MC3T3-E1 
Preosteoblasts 
plated on HAp-
Gemosil, HAp-
Gemosilamine, 
and control 
samples. Viability 
was similar for all 
three substrates 
tested. 
 
 
 
3.7 Conclusions 
In summary, we have designed a new composite, HAp-Gemosilamine, to combine the 
favorable aspects of HAp-Gel, enTMOS, and PD into a single useful composite with possible 
tissue scaffolding applications. While working with this material, interesting results relating to 
the processing temperature dependence of mechanical properties were observed. When being 
processed under low temperature (e.g., – 20 °C) before being allowed to warm up (e.g., 20 °C) 
for final setting, HAp-Gemosilamine showed improved mechanical properties than those of 
HAp-Gemosil. In contrast, processing HAp-Gemosilamine in a manner similar to the original 
HAp-Gemosil (e.g., entirely at 20 °C) only resulted in poor mechanical properties. Such a strong 
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temperature dependence behavior can be ascribed to the different temperature related 
polymerization kinetics for the PD formation and the enTMOS sol-gel reaction, as demonstrated 
by control experiments with one component individually. For example, samples which were 
processed at – 20 °C showed little to no appreciable enTMOS reaction over several hours. 
During this time, however, PD reactions are able to proceed relatively unhindered. Since both 
polymerizations are initiated by adding the aqueous phase to the composite powder blend, it is 
important to have control over which reactions proceed first. This allows a more extensive PD 
network to form before the practical multi-component based composite is warmed up for the 
final setting, caused by hydrolysis condensation of alkoxysilanes present on enTMOS. This 
interesting feature allows a brief time window during which the injected materials can fill 
arbitrary shapes, which can be very useful in tissue scaffolding applications. As a proof-of-
concept, a simple scaffold was prepared by indirect 3D printing this material, as shown in Figure 
3.6.  
 
 
 
Figure 3.6 Computed Tomography (CT) image of the 3D 
scaffold is made of 3D printing and an indirect scaffolding 
technique. Briefly, a 3D printing wax mold was used to cast 
the HAp-Gemosilamine, from which the wax was leached and 
the 3D HAp-Gemosilamine scaffold was designed. 
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Furthermore, it was shown that these composites also maintain the biocompatibility of HAp-
Gemosil materials. This is a crucial consideration for materials designed with potential tissue 
engineering applications in mind. Because HAp-Gel and enTMOS were shown to be 
biocompatible in previous studies, it was vital that the inclusion of PD did not negatively affect 
this aspect of the composite. However, the results obtained from MTS assays with plated 
preosteoblast cells show that this substrate shows nearly no difference when compared to control 
and HAp-Gemosil samples. This demonstrates dopamine’s ability to polymerize into a useful 
material for biological implants without causing a negative biological response. The results of 
the 21 day assay also demonstrate that these cells are able to proliferate unhindered over time on 
this material, suggesting also that unreacted monomer and fast degradation times are not a 
problem for this composite. Though more testing is necessary to determine the full potential of 
the new HAp-Gemosilamine as a scaffolding material, the initial results are very promising and 
demonstrate clear advantages to using PD as an additive in bioceramic materials and using 
temperature as a means for controlling subsequent polymerizations within such materials. 
3.8 Experimental Details 
Materials and Methods 
HAp-Gel slurry was prepared according to the previous co-precipitation method developed 
by Chang et al.12 The HAp-Gel slurries were freeze-dried at – 80 °C overnight followed by 
lyophilization until dry to form HAp-Gel powder. The Ca(OH)2 was derived by hydration of 
CaO which was previously calcinated at 1250 °C for 3 hours.13 enTMOS and dopamine∙HCl 
were purchased from Gelest, Inc. (Morrisville, PA, USA) and Alfa Aesar, respectively. 
Designing and Formulating HAp-Gemosilamine Composites 
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100 mg of HAp-Gel/HAp, 200 mg of Ca(OH)2 powder, and 10 mg of dopamine∙HCl powder 
were transferred into a mortar and grinded into fine powder. For “cold” samples, the powder 
mixture was spread on a cold stage to maintain a depressed temperature of – 20 °C. In the cold 
stage, 383 μL of 62% enTMOS was added to the mixture while the powders and enTMOS were 
continuously spatulated for 30 seconds. For “warm” samples, spatulating was done at 20 °C 
without utilizing the cold stage. After spatulating, 40 µL ammonium persulfate solution (1 M in 
PBS 1×) was added to the mixture to initiate the polydopamine reaction. At this state, the 
mixture became dark fluid, which can then be injected into a mold to create arbitrary-shaped 
samples. Once leaving the cold stage, the fluid solidified and stopped shape change within 3 
minutes. The samples without dopamine were also made for comparison (denoted as HAp-
Gemosil). 
Compressive and Biaxial Flexural Testing 
Cylindrical model with a 1:2 ratio of diameter (3.5 mm) to length (7.0 mm) was used to 
prepare compressive samples at two conditions: with and without cold stage mixing. All samples 
were dehydrated at the room temperature for 7 days. Compressive testing was performed on an 
Instron machine (model 4204, Canton, MA, USA) with a cross-head speed of 0.5 mm/min. The 
compressive strength was determined from the maximum strength value on the stress-strain 
curve. The testing procedure for the biaxial flexure strength was also performed according to 
methods established in our previous publication.4 Briefly, disk samples (11 mm diameter by 2.7 
mm thickness) of each group were prepared in Teflon molds. The upper and lower surfaces were 
polished in order to obtain parallel surfaces. A crosshead speed of 0.5 mm/min was used, and the 
maximum force at failure (P) was determined using an Instron 4411 Machine (model 4411, 
Instron Co., Norwood, MA, USA). A Poisson’s ratio of 0.3 was used and the flexure stress at 
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failure was calculated. Five samples for each group were used in the above testing. The testing 
results were analyzed by one-way ANOVA. 
Mass-Loss Experiments 
Mass-loss experiments were conducted as follows. 200 µL of enTMOS was diluted and 
mixed thoroughly with 250 µL of a 95% v/v MeOH/H2O solution in a pre-weighed 2 mL flask. 
This mixture was then allowed to set for a predetermined period of time. After this time, 
resulting material was rinsed 3 times with chloroform and 3 times with acetone. The residual 
solid remaining in the flask was then heated for 24 hours at 100 °C to remove any residual 
solvent. After 24 hours, the glassy material was again weighed to determine the % mass lost 
during the rinsing phase. For samples at – 20 °C, an identical approach was taken, however all 
reagents were kept at – 20 °C for 24 hours before mixing. After mixing the pre-cooled reagents, 
the material was then stored at – 20 °C for the duration of the time interval until it was finally 
rinsed and heated as above.  
UV-vis Experiments 
Progress of dopamine oxidative polymerizations was monitored via UV-vis spectroscopy as 
follows. Dopamine (2 mL, 0.05 M in MeOH) was added to 1 mL of a saturated NaOH solution 
in MeOH. This mixture was probed every 30 sec for 6 min at 350 nm. In order to investigate the 
reactions at – 20 °C, cold dopamine and NaOH solutions were mixed and stored in a controlled 
environment at – 20 °C. Again, measurements were taken every 30 sec for 6 min at 350 nm, and 
samples were kept cold until immediately prior to measurement.  
Osteoblast Proliferation Assay 
Preosteoblasts MC3T3-E1 was used to test viability of the materials in 35mm culture dishes. 
Cells were seeded at a density of 1× 104 per milliliter using αMEM medium supplemented with 
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10% of FBS and 1% penicillin/streptomycin under 37 °C, 5% CO2 atmosphere. Three groups 
were investigated, including HAp-Gemosil, HAp-Gemosilamine, and dishes as received without 
coating (control). The spin coating method was described in the previous reports13,14 and the 
coated dishes were UV sterilized and dried for 7 days, which were soaked in 2 ml PBS overnight 
prior to cell seeding. After 1, 4, 7, 14, and 21 days in culture, 40 µL of 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) reagent 
(Promega, Madison, WI, USA) was added to each dish containing 400 µL of Alpha Minimal 
Essential Media (α-MEM, Sigma-Aldrich, St. Louis, MO, USA), and the dish was incubated for 
1 hour at 37 °C under a humidified atmosphere of 5% CO2. Each sample was triplicated by 
culturing three dishes and each dish was measured three times by transferring 100 µL of MTS 
solution into each well of the 96-well plate. The absorbance of each well at 490 nm was 
measured using a microplate reader (Microplate Reader 550, Bio-Rad laboratories, Philadelphia, 
PA, USA). Relative cell numbers were quantified on the basis of the concentration of the 
formazan product of MTS. Coated dishes with HAp-Gemosil and HAp-Gemosilamine without 
cells were used as a blank (background substrate). 
3D Printing of HAp-Gemosilamine  
A computer generated 3D cylindrical porous template (10 mm diameter by 6 mm height) was 
design using SolidWork software (Dassault Systemes SolidWorks Co., Waltham, MA, USA). 
The computer template (stl format) was used to print a 3D polysulfonate mode with 1mm square 
trusses and 1mm square pore size (continuous space), which was used to cast the HAp-
Gemosilamine. The Solidscape 3D printer (Solidscape Inc., Merrimack, NH) was used to 
fabricate polysulfonate mode. The HAp-Gemosilamine mixture was prepared on the cold plate as 
described above and injected to fill up the pore spaces of the polysulfonate mode while the 
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material was in liquid form. The HAp-Gemosilamine was set within 3-5 minutes in room 
temperature. The polysulfonate and HAp-Gemosilamine complex was then immersed in acetone 
for 30 minutes to remove the polysulfonate template. The 3D porous HAp-Gemosilamine 
scaffold is shown in Figure 3.6. 
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CHAPTER 4: INVESTIGATING NOVEL CATECHOLAMINES FOR ADHESIVE 
APPLICATIONS 
 
 
In the previous chapter, the catecholamine polydopamine (PD), was incorporated into 
HAp-Gemosil materials and helped to improve adhesion between the various components of 
these bioceramic composites. This route was chosen because dopamine’s ability to polymerize 
under oxidative conditions, yielding polymers with excellent adhesive qualities. This had a 
double benefit within these composite; first it allows for the formation of a polymer chain, which 
can help mimic the role of collagen and improve strength through fiber bridging. Second, this 
newly formed polymer adheres well to nearly all substrates, helping to improve short range 
interaction as well. Though examples of polydopamine’s utility are numerous, an understanding 
of its adhesive properties and the underlying chemistry is lacking.  In this chapter, dopamine and 
other catecholamines are studied more extensively to try to gain more understanding of the 
structure property relationships that lead to versatile, adhesive polymers. 
4.1. Introduction to Catecholamine inspired adhesives 
 Adhesive materials have become ubiquitous in modern society due to their ability to bond 
different materials together, allowing better stress distribution through bonded joints. This makes 
adhesives vital for fulfilling roles in nearly every aspect of life, from clothing, to construction 
materials, and even to medical applications. Utilizing adhesives also increases freedom in 
designing new materials, and accordingly improves their cost effectiveness.1 Despite 
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demonstrating value in all walks of life, fundamental problems exist for many applications, many 
having to do with maintaining their function in the presence of water.2 Studies by Comyn et. al 
have identified at least 4 ways in which water can degrade adhesives illustrated in Figure 4.1.3 
 
 
Figure 4.1 shows how water can damage adhesive bonds in 4 primary ways; the presence of water can 
create a weak boundary layer at the interface. Water can also wick into the interface, causing loosening. 
Water can also hydrolyze and erode adhesives, or it can swell and cause increased plasticiziation, 
harming material adhesive interfaces. 
 
Despite the inherent drawbacks that water can pose to adhesives, necessity dictates that 
many adhesives must perform their tasks in aqueous environments. This presents substantial 
difficulty in designing and perfecting these materials. As mentioned in Chapter 3, the ocean 
presents a plethora of useful targets to investigate for  potential biomimetic inspirations for 
solutions to this problem. In the sea there are many plants and animals which are capable of 
sticking to numerous substrates. All of these adhesive interactions seen in aquatic life are set, and 
persist in aqueous environments. One which has caused a great deal of frustration to ships is 
known as mytilus edulis, the blue mussel. These sessile invertebrates depend on their ability to 
adhere to wet surfaces to survive. By anchoring themselves to docks and ships, they are able to 
benefit from the high rate of gas exchange and abundant flow of nutrients hugely found around 
rough waters. This makes their seemingly hostile environment an ideal location for collecting 
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nutrients.4 Despite the seeming disadvantages of their chosen substrates (i.e. rough water, wet 
substrates,) once attached, these mussels are incredibly difficult to remove. In fact, fouling from 
these types of marine organisms caused reported losses over $100 Million per year through 
excessive fuel consumption and required cleaning.5   
 Because of the incredible resilience shown by mussels in the face of traditionally harsh 
conditions, further studies of the chemistry allowing these exceptional properties was warranted. 
These studies revealed that 5 “foot proteins” were responsible for the remarkable adhesion 
observed in mytilus edulis. These were designated simply as mytilus edulis foot proteins (mefps) 
1-5. In particular, mefp-5 is found most commonly at the interface of the mussel “foot pad” and, 
by mass it is nearly 40% dihydroxy-phenylalanine. This residue, also known as levadopa (L-
Dopa), comprises more than 25% of the total residues of this protein.6 L-Dopa is a derivative of 
tyrosine, and is modified through the enzyme tyrosine hydroxylase. This modification is outlined 
in Figure 4.2. 4,6 Since the amino acid, levadopa is synthesized from tyrosine, and the fact that 
no tyrosine is observed in the final structure of many mefps demonstrates a significant 
expenditure of energy by the organism to convert these residues to L-Dopa.  
 
Figure 4.2 Conversion of tyrosine to L-DOPA 
 
The discovery that mytilus edulis produces so much L-Dopa prompted significant 
research into the utility of polycatechols as adhesives. It was shown that these materials were 
capable of performing well as binders of inorganic materials.7 Catechols, and their derivatives 
were also used for surface modification applications with good effect, especially on inorganic 
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surfaces.8 When processed on the appropriate surfaces and with the appropriate cross-linking 
agents, these materials were shown to also be quite versatile adhesives.9 In fact, these catechol 
based materials could be effectively cured by the addition of coordinating, oxidatively active 
ions such as  dichromate (Cr2O7)
2-  or periodate (IO4)
1- to yield highly cross-linked materials with 
potential adhesive applications.10 Furthermore, by adding charged side-chains, these adhesives 
were shown to also perform well as adhesives underwater, warranting further investigation into 
this phenomena.11   
Though this gives a good clue as to the necessity of this catechol functional group, and 
poly-catechols were observed to adhere well to various inorganic substrates,12 it was not as 
successful at binding plastics and other low energy materials.7 This demonstrated that, while the 
catechol group is necessary for binding, it is not the only molecule involved. Furthermore, the 
discovery by White et al. that the coexistence of charged amine groups in the vicinity of the 
polycatechols had profound implications on the performance of these adhesives.11 Further 
investigation of mefp-5 was able to show that more than 75% of these catecholic L-Dopa 
residues were flanked by a basic residue (i.e. lysine, arginine, and histidine.) In fact, L-Dopa and 
its surrounding basic residues were shown to comprise approximately 65 weight% and over 50 
mol% of all residues present in these binding proteins, strongly implying that the coexistence of 
both the catechol and a nearby amine was the key to good adhesion. The structures and mol% of 
relevant amino-acid residues present in mefp-5 is given in Figure 4.3. 
 
Figure 4.3 Structures of major Amino Acids in 
Mytilus Edulis Foot Proteins 
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This discovery led to a groundbreaking study in 2007 by Lee et al., which demonstrated 
the utility of oxidatively polymerizing dopamine to form polydopamine (PD).13 This common 
neurotransmitter presents a greatly simplified structure when compared to the complex proteins 
found in mytilus edulis. Despite this simplified structure, dopamine still possessing the two main 
functional groups shown to give good adhesive properties; a catechol and an amine. By exposing 
dopamine to basic conditions (pH >8.5), it is able to polymerize, yielding a macromolecule 
which demonstrates adhesive properties very similar to those observed through various mefps. 
These original works by Messersmith et al and numerous subsequent publications have 
demonstrated the ability of PD to adhere to numerous substrates, beyond those of poly-
catechols.7 The behavior of PD is unique in that it gives the opportunity to change a surface’s 
chemistry in a single step, unlike other methods.14  Because this route yielded polymers which 
were able to adhere to virtually all substrates under numerous conditions, substantial effort has 
been put forth in order to understand the mechanism by which this macromolecule forms, and 
what functionalities give it such amazing adhesive properties. Despite this work, no clear 
consensus has been reached as to the mechanism or the final structure of the PD macromolecule 
that leads to favorable adhesive properties.15 Early studies hypothesized that the likely the 
structure of polydopamine was formed through covalent attachment through the aromatic 
protons.  The structure originally proposed by Messersmith et al13 and others16 is given in Figure 
4.4. 
This structure was hypothesized due to the structural similarity between dopamine and 
the biopolymer eumelanin.17 The Eumelanin polymer plays a major role in hair pigments, and is 
formed through the polymerization of 5, 6-dihydroxyindole (DHI) and 5, 6-dihydroxyindole-2-
carboxylic acid (DHICA).  In fact, dopamine, DHI, and DHICA are all formed originally from 
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tyrosine and levodopa as different branches along the same biosynthetic pathway, which shown 
in Figure 4.5. This scheme also shows the eumelanin polymer which was the inspiration for the 
dopamine polymerization proposed in Figure 4.4. 
 
 
Figure 4.4 Early proposed 
mechanism for the 
polymerization of dopamine 
 
 
 
 
 
 
 
 
Figure 4.5 Dopamine and 
Eumelanin synthetic 
pathways, showing 
structural similarities 
 
 
 
 
 
 
Other work has suggested that PD does not contain covalent bonds, but instead is a 
supramolecular aggregate of dopamine monomers and their derivatives (e.g. 5, 6-
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dihydroxyindoline, and its dione derivative.) It has been claimed by Bielawski et al. that these 
monomers are held together through a combination of non-covalent interactions14 (similar to 
those observed with benzoquinone and a diol.)18 This scheme follows three major steps to get to 
macromolecules based on dopamine (or other tyrosine derivatives.) First, oxidation of the 
catechol hydroxyls to carbonyls allows cyclization of a pendant amine to follow shortly 
thereafter. Then, polymerization is achieved via charge transfer, hydrogen bonding and or π-
stacking interactions, creating the non-covalent polymer. These key steps and another 
hypothetical structure of PD are given below in Figure 4.6. 
 
 
Figure 4.6 Shows the proposed non-covalent assembly of dopamine leading to polydopamine 
proposed by Bielawksi 
 
Other work has suggested a combination of these previous structures; a small number of 
dimers and trimers are able to form, which are then able to pi-stack and hydrogen bond to form a 
macromolecule held together by a combination of covalent and non-covalent interactions. Lee et 
al.  were able to show evidence for both covalent attachment, and π-stacking interactions.19 They 
have recently proposed a mechanism involving the formation of dopamine-DHI dimers and 
trimers which are then able to stack 3-dimensionally through π-stacking, yielding a 
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macromolecule which forms as a combination of oxidative polymerization (similar to 
eumelanin)17 and physical self-assembly (similar to benzoquinone and diols.)18  
A few attempts at simplifying the structure of catecholamines have been published, 
though these mostly focused on using polymeric mimics of mefps. For example, Wilker et al. 
was able to use catecholamines which mimic a simplified mefp structure in order to obtain 
excellent adhesive properties on numerous surfaces. These studies demonstrated that these 
materials were indeed capable of modifying a surface and making adhesive films, helping to 
demonstrate the unique properties of catecholamines other than dopamine.7, 16, 20 While little is 
known with certainty about the final macromolecular structure of PD, much is known about its 
ability to modify surfaces and alter properties of numerous substrates.21 22However, since 
mechanistic and structural information is lacking, less work has been devoted to expanding the 
scope of catecholamines involved in surface modification.  
When studying mefps in the context of dopamine, it becomes apparent that the structure 
of dopamine may not be as important as originally thought. In fact, nothing in the structure of 
mefps demonstrates that these functional groups need to be covalently bound, but rather that they 
simply need to be found close to one another. This is apparent when considering the numerous 
bonds separating the catechol and amine moieties. With this organization, the amine and catechol 
don’t “know” they are attached, as they do not feel the effects of one another directly. Rather, 
they simply feel the effects due to their localization in the protein’s tertiary structure. This 
rationale suggests that a solution containing unbound catecholamines (i.e. no covalent 
attachment of catechol and amine moieties) of sufficient concentration could also polymerize 
into an adhesive composite. 
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While these early studies were important in showing that mefp mimics can be more 
versatile than dopamine, they did not investigate unbound catecholamines. This study attempts to 
simplify catecholamine adhesive formulations even farther, in order to gain a better fundamental 
understanding of catecholamine systems. Furthermore, by using unbound catecholamine pairs, it 
should be possible to help understand why these unique physical properties exist for this class of 
materials.  It is also hoped that by studying derivatized catecholamines, it will become clearer 
what structural features lead to the remarkable properties of dopamine and other catecholamine 
analogs.  
4.2 Using untethered catechol-amine pairs to mimic polydopamine  
 When investigating alternative catecholamines for polymerization, one of the simplest 
mimics allowing investigation into the importance of the covalent attachment seen in dopamine 
would be propyl amine (PA) and catechol. The structures of these molecules are given along 
with dopamine in Figure 4.7. This was an attractive alternative to dopamine as these two 
molecules are substantially cheaper than while still preserving the relevant functional groups 
hypothesized to be important for the remarkable adhesion of catecholamines. Furthermore, if an 
unbound catecholamine pair like Cat-PA is able to behave similarly to PD, it will have profound 
implications on the design in novel adhesive systems in the future.   
 
 
 
 
Figure 4.7 Structures of initial test catecholamines; the “bound” pair dopamine, and the “unbound” 
pair, catechol and propylamine . 
 
According to the work of Wei et al, a simple method for monitoring the progress of 
dopamine polymerization is through the UV absorption at 350nm, which is related to the 
 85 
formation of the quinone. This oxidation is widely agreed upon to be an important first step in 
the polymerization of dopamine.14,19,23 This is followed by a broad peak developing around 
480nm, indicative of further polymerization caused by 1,4-Michael addition of the amine. 23 
These reactions are accompanied by a characteristic color change in solution. Initially, it was 
noticed that Cat-PA pairs also exhibited this unique color change upon mixing, and monitoring 
its UV-Vis profile can help give information about catecholamine polymerizations. Normally for 
these oxidative polymerizations, dopamine requires the addition of a basic component and or an 
oxidant to initiate the polymerization. However, when utilizing propyl amine this becomes 
unnecessary, as PA is sufficiently basic to oxidize catechol on its own. The PD and Cat-PA pairs 
were allowed to polymerize for 5 minutes, with data being collected every minute to observe the 
similarities and differences between the two systems, and this experiment is shown in Figure 
4.8.  
 
Figure 4.8 UV-Vis spectra from 700-300nm for a.) Cat-PA and b.) Polydopamine over 5 minutes 
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By mixing Cat-PA in a 1:1 stoichiometric loading at the same concentration as dopamine, the 
same concentration of each functional group is present in both solutions. This helps to identify if 
it is the covalent linkage, or simply the concentration, that is the important factor in 
catecholamine polymerizations. It can clearly be seen in Figure 4.8 that the combination of Cat-
PA shows distinct similarities to PD, through the growth of the characteristic quinone peak at 
350nm. Both pairs also show a peak appearing in the 480nm range, which is absent from 
catechol only samples. This indicates the unbound amine is still playing an important role in 
solution. However, the shape of the PD and Cat-PA curves are slightly different, suggesting a 
different macromolecular structure forming in Cat-PA than observed in PD. Though on its own, 
this evidence is insufficient to claim the similarity between these systems, this result presents an 
excellent starting point for investigating the similarities between the ‘bound’ catecholamine, 
dopamine, and its ‘unbound’ analog, Cat-PA. By comparing these 2 systems side by side, it 
becomes easier to understand the similarities and differences found between catecholamines and 
to help understand better the applicability of this system.  
4.3 Film Deposition studies 
 The ability to form films is crucial to PD’s ability to modify the surface of numerous 
substrates and also lies at the heart of its amazing adhesive abilities. After confirming that unique 
reactions do take place between simplified unbound catecholamines, it was important to study 
their ability to deposit films as well. X-Ray photoelectron spectroscopy is a technique which 
utilizes X-rays to probe the surface chemistry of a material. This allows the composition of a 
material surface to be elucidated, and provides a way to investigate the ability of materials to 
deposit films on a surface. This technique also allows an estimation of the thickness of a 
deposited material. Preliminary studies were done comparing PD to Cat-PA by soaking both gold 
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in these solutions and using XPS to determine the ratio of C and N signals (from catecholamines) 
to that of Au surface signals. A sample of these results is given in Figure 4.9. 
This XPS data illustrates another striking similarity between the behavior of PD and Cat-
PA. Both were capable of coating the surface, shown by the increasing ratio of C and N signals 
compared to gold. The appearance of the Na and Cl peaks present in PD films is a result of the 
added NaOH in order to alter the pH to initiate polymerization. These data clearly indicates that 
films have been deposited, and surprisingly, the Cat-PA combination was shown to have actually 
deposited a thicker film (15.5nm) than PD (5nm) over the course of 24 hours. 
 
   
Figure 4.9 XPS Data for PD (left) and Cat-PA (right) on Au substrates 
 
These solutions were also compared against the control sample of catechol treated in identical 
conditions to PD which produced a thinner film, with a thickness of just 2.8nm. This indicates 
that the reaction of Cat-PA is beyond that of simply oxidizing catechol in the presence of another 
base.  
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 The utility of catecholamines stems not only from their ability to deposit films, but their 
ability to deposit films on numerous substrates. For this reason, a less favorable substrate was 
also investigated. Glass was chosen for its transparency, making spectroscopic tracking of film 
deposition easier. Glass slides were allowed to soak in a solution of PD and Cat-PA over the 
course of 5 hours, with a sample being removed every hour for spectroscopic investigation. 
These results are shown in Figure 4.10. 
 
Figure 4.10 Film Deposition for a.) Cat-PA and b.) PD on glass over 5 hours 
 
  
Though the spectra look less similar than those observed for solution polymerizations, 
indicating a potentially different macromolecular structure on the surface, it can clearly be seen 
that both materials were capable of depositing films of increasing thickness over time. These 
glass slides were visibly altered to a very similar brown color, characteristic of dopamine 
oxidation and polymerization.13 Furthermore, the observation that these films grew over time is a 
good indication that they are capable of adhering to the materials surface and polymerizing from 
there. The UV-Vis signal from 350nm was plotted against time to give an idea of film deposition 
rate for both PD and Cat-PA and is given in Figure 4.11. These data clearly show the increasing 
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film thickness over time. This is an important consideration for adhesion, as the molecule must 
form a good interface with the surface in order to create a good adhesive bond.  
 
 
 
 
 
Figure 4.11 Demonstration of film growth 
on glass slides via absorbance at 350nm 
over 5 hours for Cat-PA and PD. The 
increase in absorbance indicates thicker 
films over time. 
 
 
 
 
 
4.4 Film Adhesion Studies 
 As mentioned previously, substantial work has been devoted to understanding and 
replicating the unique adhesive properties of PD. Therefore, the ultimate test for the similarity 
between Cat-PA comes by testing its adhesive strength. To accomplish this, solutions of various 
catecholamine pairs, including dopamine, were pressed between glass slides in order to measure 
their maximum load at failure. By adhering two glass substrates together, it is possible to 
measure the adhesive force by utilizing lap-shear testing methods. This involves pulling laterally 
across the adhered surface, trying to separate the adherents by rupturing the adhesive material. 
This helps give a clear indication as to the adhesive ability of these materials, as better adhesives 
will show a greater load at failure. Additional catecholamines were chosen in order to investigate 
how vital the structure of dopamine was to the adhesive properties. In its place were two 
catecholamine pairs; dopamine with stoichiometric propylamine, and catechol with 
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poly(ethylenimine). Additionally, catechol was tested under the same conditions as the previous 
catecholamine pairs in order to ensure that the effect being observed was more than simple 
oxidation of catechol leading to adhesion. After determining the stress at break, it was easy to 
calculate the adhesive force for each sample. This was done by dividing the maximum load at 
failure, in Newtons, by the measured area of adhesive overlap in square meters.  Representative 
stress-strain curves from these experiments are given in Figure 4.12, and a summary of the 
performance of these catecholamines is given in Table 4.1  
 
Figure 4.12 (a) Adhesive force for various catecholamines, calculated from (b) Stress-strain curves 
demonstrating the maximum load at failure for each catecholamine adhesive formulation 
 
For these tests, pure propylamine and PEI did not provide appreciable adhesion, but 
rather acted as a viscous layer between the slides, which began sliding at the application of force. 
With that in mind, these data clearly support the theory that other catecholamines, beyond 
dopamine, can demonstrate favorable surface interactions and adhesive properties. This is 
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Table 4.1 Results from Adhesive testing of Catecholamines 
 
Sample Force at Break 
(N) 
Std. Deviation 
(%) 
Adhesive strength 
(MPa) 
Catechol + Propylamine 103.6667 13.2 0.169252 
Catechol Control 59.8 12.7 0.097 
Catechol +PEI 113.7 24.9 0.186 
Dopamine 179.3 14.3 0.293 
 
confirmed by the fact that both of the catecholamine pairs tested (i.e. Cat-PA and Cat-PEI) had 
improved adhesive properties when compared to catechol without an amine source. The graphs 
in Figure 4.12 demonstrate a long period of time during which the adhesive is resisting the 
increasing load from the Instron.  This resistance to the input stress increases until there is a 
sharp drop, indicating bond breaking and adhesive failure.   
 Interestingly, neither of the novel catecholamine adhesives tested was able to surpass the 
performance of PD. This implies that, while binding of catechol and amine moieties is not 
required, it may be important to improved adhesive properties. This would make sense, as the 
covalent attachment of catechol and amine, as seen in dopamine, could provide two distinct 
advantages. First, the tethering of the catechol and amine moieties helps to keep their local 
concentration, presenting the possibility for faster reaction times (i.e. the amine is close to the 
oxidized catechol at all times, helping facilitate 1,4 Michael addition/cyclization prior to 
polymerization, as seen in Figure 4.4) Second, the covalent attachment could help improve the 
strength of this material by providing another bond which must be broken in order to rupture the 
adhesive. This is also suggested by the performance of the Cat-PEI pairs compared to the Cat-PA 
pairs, since the polymeric amine present on PEI provided better adhesion than the small 
molecule amine from propylamine.  
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4.5 Conclusions 
 In summary, we have demonstrated that the adhesive behavior observed with dopamine 
and other mefp analogs is a broader phenomenon than originally believed. Close examination of 
the mefps which inspired this research suggested that the local concentration of an amine and 
catechol in solution was the key to their remarkable properties. Early attempts to mimic the 
function of mefps focused on using either synthetic polymer analogs(e.g. polymeric 
catechol/amines)9,10 or bound small molecule catecholamine pairs (e.g. dopamine)13 but none 
capitalized on simpler, unbound small molecule catecholamines. The results obtained regarding 
both film deposition and adhesive studies suggest that it is indeed the local concentration leading 
to catecholamine adhesion. The unbound catecholamine adhesives outperformed oxidized 
catechol alone in adhesive strength and film deposition, and performed similarly to PD. 
While this adhesive interaction is not governed by covalent attachment of the catechol 
and amine, there were some indications that this covalent attachment did lead to improved 
adhesive properties. Adhesive strength of PD did outperform all of the unbound catecholamine 
pairs tested. Though using a polymeric amine component did seem to improve the overall 
adhesion demonstrated by unbound catechol/amine pairs. These results highlight that the 
covalent attachment of catechol and amine is not vital to observe the unique adhesive properties 
of these materials, but it may impart improved adhesive performance for these composites.  
The fact that this catechol/amine adhesive interaction is more universal than originally 
thought opens the door for new studies into the applications of these materials. This discovery 
has profound implications for new routes towards surface modification, tunable polymers, and 
adhesives. By showing that catecholamine adhesives are more universally applicable, it becomes 
possible to use small molecules and polymers with special properties introduced through their 
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design. This allows more high performance materials to take advantage of the unique properties 
afforded by catecholamine adhesives, without the need to focus on dopamine analogs 
specifically. 
4.6 Experimental  
Materials and Methods 
 Dopamine-HCl and glass slides were purchased from Fisher and used as received. 
Catechol, Propylamine, PEI, and NaOH were purchased from Sigma-Aldrich and used as 
received. 
XPS Study 
Films for XPS studies were prepared by soaking Au coated gold in a solution of 
catecholamine for 24 hours. For PD samples, of 0.1M Dopamine in water, adjusted to pH 9 using 
1M NaOH, was used. For catechol /propylamine, a 0.2M solution of catechol was mixed 1:1 
with a 0.2M solution of propylamine, to yield a 0.1M solution of catechol/propylamine in water. 
After 24 hours, the samples were removed and excess solvent was removed using compressed air 
before the sample was allowed to sit for additional 24 hours before testing.  The results of these 
experiments are given in Figure 4.9. 
UV-Vis Study 
The progress of catecholamine polymerizations was monitored as follows. 0.1M solutions 
of PD and Catechol/propylamine were prepared as stated above. For UV-Vis experiments, these 
solutions were then used to soak glass slides over the course of 5 hours, with a slide being 
removed every hour.  After soaking, these samples were dried using compressed air and allowed 
to sit for an additional 24 hours before testing.  These slides were scanned from 300-700nm 
utilizing a blank slide as a reference (Figure 4.8.) According to Wei et al, special attention was 
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paid to the signal at 350nm, which has been attributed to the polymerization of dopamine, and 
the absorbance at this point was used to show increasing film thickness over time for these 
samples (Figure 4.10 and 4.11) 
Adhesive Testing  
 Adhesive tests were done using polished glass slides as a substrate for adhesion. To make 
adhesive samples, a solution of catecholamine 1% by weight was prepared. From this solution, 
30uL was pipetted onto a 24.5x25mm square on one of the slides. The other slide was then 
placed on top and pressed to remove excess solvent. This slide was then clamped together to give 
the slides adequate time to adhere. After 48 hours, the samples are sufficiently dry to allow 
testing. These samples were then loaded onto an Instron 5566 mechanical testing apparatus for 
lap shear testing. These tests involved subjecting the sample to a 2mm/min elongation until 
break. After breaking, the final load at break was then used to calculate the total adhesive force 
indirectly. Results from these experiments are given in Figure 4.12 and Table 4.1. 
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CHAPTER 5:CONCLUSIONS AND FUTURE DIRECTIONS 
 
 The primary aim of this dissertation was to study and improve synthetic bone 
replacement materials in order to provide better treatment options. In Chapter 2, biomimetic 
approaches to improving bioceramic composites were explored, demonstrating that the addition 
of a polymeric component helped to improve fiber bridging in the composite. In Chapter 3, the 
adhesive catecholamine polymer polydopamine (PD) was utilized in order to improve the 
compressive modulus of bioceramic materials. The processing of these materials was shown to 
have profound implications on the mechanical performance of these composites, as proper 
temperature control could yield interpenetrating polymer networks, maximizing strength. In 
Chapter 4, we examined the adhesive ability of other, previously untested, catecholamine 
formulations. Unlike previous work, we attempted to use catecholamine combinations which 
were not covalently bound in order to gain a better understanding of the structure-property 
relationship which give these materials their remarkable properties. These materials ultimately 
demonstrated properties similar to PD, indicating a more generally applicable structure is 
capable of yielding these unique adhesive properties.  The discoveries of Chapter 3 and 
Chapter 4 presented two new avenues for investigation while continuing work on this project; 
studying new catecholamines as a route to improve bioceramics, and studying new 
catecholamines designed to help improve our understanding of these unique polymers. 
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5.1 Plans for Improving Biomimetic Composites 
 Our initial results indicated that the inclusion of an adhesive polymer yielded improved 
mechanical properties in bioceramic materials. We were also able to broader applicability of 
catecholamine adhesives. Future works will focus on designing and preparing biomimetic 
polymers which can utilize dopamine cross-linking to try to design stronger composites 
compared to previously established HAp-Gemosil and HAp-Gemosilamine materials. Also, by 
grafting these monomers onto a degradable polymer backbone, it is possible to have these 
polymeric components be temporary, alleviating problems with the permanence of silanes used 
in our previously studying enTMOS containing composites.   
 Further tests can be conducted on modified small-molecule catecholamines in these 
composites. By utilizing peptides or other biomolecules, we can improve and proliferation of 
cells as well, helping to increase osteoconductivity of our bioceramics. Additives can also be 
added to these small molecule catecholamine blends to attempt to cross-link,1 to improve 
strength without the need for polymeric components. 
5.2 Further Studies on Catecholamine Adhesives 
Since PD was the initial inspiration into our investigations of catecholamines, but no 
clear mechanistic understanding of its macromolecular structure, it is important to continue to 
investigate this aspect of the material. As previously reported, no clear final structure exists for 
PD, though several sources claim that cyclization of the amine is an important step in the 
polymerization of this catecholamine.2-4 While our tests showed that unbound catecholamines do 
also polymerize, demonstrating the fact that cyclization is not important, they also demonstrated 
that the bound catecholamines do show slightly improved mechanical properties when compared 
to the unbound pairs we investigated.  To further probe these results, simple dopamine analogs 
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can be created, utilizing longer linker chains between the amine and catechol like those shown in 
Figure 5.1.  
 
Figure 5.1 Structure of dopamine analogs with longer side chains and a generic representation of their 
prospective polymers 
 
Dopamine’s 2 carbon linker allows it to form a 5 membered ring fused to the catechol 
ring. If this monomer structure is expanded to include 3 or 4 carbon atoms, it is possible to form 
6 and 7 membered fused rings, which should both also be energetically favorable to form. This 
will help gain an understanding if this 5 membered ring is important to the function and 
properties of dopamine, or if this is unimportant. Further tests could involve dopamine analogs 
with very long chains (i.e. >10 carbon units,) in order to determine if these are more similar to 
bound (e.g. dopamine) or unbound (e.g. Cat-PA) catecholamines.  By mechanically testing these 
materials, and comparing them to both PD and other unbound catecholamine pairs, we can also 
gain a better understanding of the molecular structure which leads to the excellent adhesive 
properties previously reported for PD.  
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 Further studies are also planned to block the 5 position on the catechol ring (which is 
where the covalent bonding to fuse the rings together takes place.) These studies should prevent 
cyclization of dopamine derivatives, and should give further clues and understanding of the 
mechanistic picture regarding the polymerization of not only dopamine, and also improves our 
understanding of these materials as adhesives. Furthermore, if the 4 and 5 positions on catechol 
are blocked and this molecule is treated with propylamine, we will be able to determine if there 
is covalent attachment between PA and catechol that also helps improve adhesion compared to 
catechol alone.  
5.3 Improving Adhesive properties 
 Although we have shown that it is not necessary to have the catechol and amine bound 
together to gain the favorable properties of catecholamines like dopamine, we also discovered 
that these molecules being bound is important for improving properties.  It was seen that 
dopamine exhibited superior adhesion than Cat-PA solutions. Furthermore, we discovered that 
mixing catechol with a polymeric amine yielded better properties than propyl amine, suggesting 
polymers can indeed improve properties of these adhesives.  In fact, several attempts at utilizing 
various poly-catechol and poly-amine pairs have already been established.5,6 By functionalizing a 
catechol and an amine molecule with a synthetic handle, it becomes possible to “click” these 
molecules on to polymers possessing the appropriate synthetic handle. It would then be possible 
to functionalize nearly any polymer, or small molecule in order to convert it to an adhesive 
through the utilization of polydopamine. We plan to explore how broadly applicable this system 
is and whether or not favorable adhesive properties can be imparted onto other polymers 
important for biomedical applications (e.g. MMA, LLA, TMC) or other traditionally non-stick 
polymers (e.g. PDMS, PTFE.) Furthermore, we would like to investigate the combination 
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catechol-modified surfaces with amine functionalized polymers to attempt to investigate if these 
are capable of forming reversible adhesive as cartooned in Figure 5.2 
 
 
 
  
 
 
 
Figure 5.2 Proposed route towards reversible adhesion 
on catechol modified substrates.  
.  
 
 
 
 
These experiments will help further our understanding of these materials in order to allow the 
synthesis of specialized catecholamines functionalized materials.  
5.4 Concluding Remarks  
Several promising materials have been developed for the replacement of bone tissue, 
however, none of these have proven an ideal replacement for damaged tissue. To find better 
materials suitable for these applications, synergistic research efforts from chemists, doctors and 
engineers is required. This allows a focused approach to designing, synthesizing, and studying 
novel materials for their therapeutic abilities. Furthermore, novel materials must be explored in 
order to impart new properties into these tissue replacement materials. This work presents just a 
small piece of that puzzle, designed to help further our understanding of bioceramic composites 
and adhesives components used therein. By focusing on our fundamental understanding of the 
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interactions between polymers and ceramics, as well as better understanding macromolecular 
catecholamine adhesives, it will be possible to continue to present improved treatment options.  
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